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ABSTRACT
Methylphenidate (MPH) has proven efficacy with the 
disruptive behaviors of children with ADHD in regular 
education settings (Gully and Northup, 1997; Northup et 
el., 1999; in press). Blum, Mauk, McComas, and Mace (1996) 
researched the separate and combined effects of behavioral 
and MPH treatments on the task engagement and disruptive 
behavior of 3 children with severe to profound mental 
retardation. This study used a single-subject, multielement 
or alternating treatment design to assess the separate and 
combined effects of MPH and behavioral treatments on the 
performance of 5 children with severe to profound mental 
retardation. MPH effects were evaluated within and across 
dosages. Data collected in 4 to 5 analog assessments 
(alone, escape, attention, tangible, control) determined 
the two classroom functional analysis conditions used in 
the subsequent medication evaluation. Target behavior rates 
(disruptive behavior and task engagement), care provider 
ratings of child behavior, and academic or task performance 
measures provided comparisons across 2 or 3 levels of MPH 
and placebo. Data from analog and classroom analyses were 
used to develop an appropriate, function-related behavioral 
treatment for each child that included differential 
reinforcement of appropriate behavior and graduated 
compliance. Results indicated that 3 children demonstrated 
decreased disruptive behaviors and improved task engagement 
in response to MPH while 2 children demonstrated similar
vii
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improvement in response to the behavior intervention. Also, 
this study (a) determined the differential effects that 
stimulant medication may have on academic and behavioral 
performance both within and across dosages, (b) compared 
the effectiveness of stimulant medication and a 
function-related intervention in controlling problematic 
behavior, and (c) determined which medication dose, if any, 
was indicated for each participant. This study extends 
previous behavior pharmacological research by utilizing 
functional analysis of behavior disorders in relation to 
medication status and developmental task variables to 
assess the behavior mechanism of drug action in medication 
efficacy studies. Conclusions are interpreted in relation 
to the utility of functional analysis in identifying 
critical assessment parameters and selecting environmental 
stimuli useful in developing behavior treatments that 
maximize drug action.
viii
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REVIEW OF THE LITERATURE 
Definition of Mental Retardation 
The definition of mental retardation has been a 
controversial issue through the years (Deitz & Repp, 1989) . 
Historically, mental retardation and mental illness have 
been strongly linked (Rosen, Clark, & Kivitz, 1976) . The 
gradual differentiation between the two disabilities began 
in the 19th century with social incompetence viewed as the 
primary indicator of disability (Deitz & Repp, 1989) . With 
the advent of memory and cognitive-perceptual tests, most 
classification systems began to distinguish between mental 
deficiency and mental illness on the basis of the 
individual's potential for reasoning and complex thought 
(Lewis & MacLean, 19 82).
By the turn of the century, emotional impairment was 
considered the primary characteristic of mental illness, 
and a cognitive deficit was considered the defining 
characteristic of mental retardation (Ollendick, Oswald, & 
Ollendick, 1993). In 1919, Terman introduced the 
score-referenced classification levels of borderline, 
moron, imbecile, and idiot and used a score of less than 80 
on the Stanford-Binet Intelligence Scale as the identifying 
criteria for retardation (Deitz & Repp, 1989). In the 
1930s, the importance of developmental delays in behavior 
existing concurrently with retardation in mental processing 
was recognized (Madle & Neisworth, 1990). In 1947, the 
Vineland Social Maturity Scale was introduced to assess
1
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basic social and daily living skills (Doll, 1947). 
Statistical distributions of intellectual scores and 
adaptive behavior estimates have been the basis of all 
subsequent definitions of mental retardation (Gresham, 
MacMillan, & Siperstein, 1995; Deitz & Repp, 1989).
Developmental disabilities are based on functional 
skill criteria and include mental retardation, autism, and 
pervasive developmental disorder not otherwise specified 
(APA, 1994). Public Law 95-602 (197 8) defines developmental 
disability as attributable to a mental or physical 
impairment, manifested before the age of 22 years, likely 
to continue indefinitely, resulting in substantial 
limitation in three or more specified areas of functioning, 
and requiring specific, lifelong or extended care. Mental 
retardation is distinctive among disorders in that its 
diagnosis is statistically derived through a cultural 
deviance rather than clinically derived through a syndrome 
of specific behaviors and symptoms (Hamilton and Matson, 
1992). The three criteria defining mental retardation are 
(a) significantly subaverage intelligence (i.e., greater 
than two standard deviations below the mean),(b) concurrent 
deficits in adaptive behavior, and (c) onset prior to age 
18 (Grossman, 1983: APA, 1994). Adaptive behavior refers to 
the degree of independent functioning skills, physical 
development, language development, and academic competency 
expected for age and cultural group (Hamilton & Matson, 
1992) .
2
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Four levels of mental retardation are specified by the 
individual's degree of intellectual and adaptive impairment 
(Madle & Neisworth, 1990; APA, 1994). Levels include mild 
(2 to 3 standard deviations below the mean), moderate (3 to 
4 standard deviations below the mean), severe (4 to 5 
standard deviations below the mean), and profound (greater 
than 5 standard deviations below the mean). When there are 
discrepant intellectual and adaptive standard scores the 
diagnosis corresponds with the higher score. Mental 
retardation, severity unspecified, is used when there is a 
strong presumption of mental retardation, but the 
individual is untestable with standard testing instruments 
(APA, 1994).
Prevalence and Etiology 
Prevalence estimates of mental retardation range from 
less than 1% to 12% with the best estimate considered to be 
about 3% during the school years and approximately 1% 
during the remainder of the lifespan (Scheerenberger, 1981; 
Madle & Neisworth, 1990). Typically, the diagnosis is more 
common at school ages and in lower socioeconomic areas. 
Approximately 10% to 15% of the population have a discrete 
medical syndrome linked to their disability.
Mental retardation usually results from an interplay 
of genetic and environmental factors where no organic 
abnormalities are directly identifiable (Baumeister &
Sevin, 1990; Deitz & Repp, 1989). Organic or genetic 
factors account for approximately 25% of all cases of
3
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mental retardation. Educational, familial, and societal 
factors also contribute to mental retardation, and 40% to 
90% of the individuals diagnosed with this disorder are 
identifiable as cultural-familial mental retardation with 
unknown etiology (Deitz & Repp, 1989).
Associated Disruptive Behaviors 
Behavioral disorders were exhibited by 10% to 6 0% of 
the individuals with developmental disabilities (Sturmey,
1995), and coping with self-injury, aggression, and 
resistance Lo supervision accounts for 48% of the support 
worker time (Thompson, Hackenberg, Cerutti, Baker, &
Axtell, 1994). Behavior disorder severity is the single 
most important variable influencing institutional placement 
and is an important factor in community placement failures 
(Bruininks, Rotegard, Lakin, & Hill, 1987; Aman & Singh,
1991). Behavior management is usually achieved through a 
combination of psychoactive medication, applied behavior 
analysis, and behavioral intervention (Baumeister & Sevin, 
1990; Madle & Neisworth, 1990). Fundamental tenets of 
behavior analysis are that behavioral disorders have a 
significant learned component and functional assessment 
methodologies have a demonstrated utility in identifying 
useful treatments (Iwata, Vollmer, Zarcone, 1990). A brief 
description of the associated behavior disturbances follows 
emphasizing aggression and self-injury, which are the two 
behaviors most likely to result in referral for medication 
(Aman & Singh, 1991).
4
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Aggression
Aggression is a behavior that occurs within a social 
context and is considered aversive to others. Included 
within most definitions are verbal and physical assault, 
fighting, destructive misuse of objects, and severe 
disruptive and noncompliant behaviors (Mulick, Hammer, & 
Dura, 1991). About 20% of the individuals living at home, 
16% to 20% of the individuals residing in community 
residential facilities, and 30% to 45% of the individuals 
in institutional settings exhibit behavior that injure 
others (Eyman, Borthwick, & Miller, 1981; Hill & Bruininks,
1984). Statistically, aggression is 1.5 to 6 times more 
prevalent among institutional new admissions, community 
placement failures, and reinstitutionalizations (Schalock, 
Harper, & Genung, 1981) . Physical violence toward others 
and property, tantrums, and explosive or disruptive acts 
interfere with the development of adaptive behaviors (e.g., 
social relationships and interactions) in a population 
defined by adaptive social deficits (Matson & Sevin, 199 3; 
Sevin & Matson, 1994). Aggression is the primary source of 
psychiatric referral among individuals with mental 
retardation (Reiss, 1982; Benson, 1985).
Stereotypy and Self- injurious Behavior (SIB)
Stereotypy and SIB are multiply determined by 
neurobiological and environmental factors (Harris, 1992). 
Both behaviors are prevalent in many medical syndromes
5
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(e.g., Lesch-Nyan, Cornelia de Lange, fragile X, Rett's, 
and Riley-Day syndromes).
Stereotypies are rhythmical, highly consistent, 
repetitive behaviors or posturing responses that are 
excessive in rate, frequency, and/or intensity, clinically 
conspicuous, socially undesirable, and topographically 
heterogeneous (Baumeister, 197 8; Rojahn & Sisson, 199 0; Fee 
& Matson, 1992). Examples include repetitive movements, 
(e.g., rocking, swaying, waving, flapping, finger play), 
self - stimulatory behaviors (e.g., sniffing, humming, 
vocalizing, mouthing, saliva or mucous play), idiosyncratic 
mannerisms (e.g., object twirling, bruxism, air swallowing) 
and blindisms (e.g., eye rubbing, poking). Stereotypy is a 
characteristic of individuals with severe to profound 
mental retardation but is also common among other clinical 
populations (e.g., blind, autistic, geriatric, mentally 
ill). Prevalence estimates vary from one to two-thirds of 
the mentally retarded population with the higher reports 
being closely related with institutional placement, 
severity of diagnosis, and early childhood and adolescence 
(Rojahn & Sisson, 1990). Clinical problems arise in 
relation to the intensity and form of the repetitive 
behavior, and defining a behavior as a stereotypy or 
self-injury is dependent on potential for tissue damage 
(Madle & Neisworth, 1990; Fee & Matson, 1992). For example, 
innocuous but repetitive, nonfunctional behaviors (e. g., 
body rocking, hand waving) may preclude essential
6
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educational or training programs. Repetitive head rocking 
may intensify into self - injurious head banging (Rojahn & 
Sisson, 1990) . The most common treatments for stereotypy 
have included behavior modification or therapy, physical 
exercise, pharmacotherapy, and structural rearrangement of 
the environment (Rojahn & Sisson, 1990) .
SIB is defined as a highly repetitive and rhythmic act 
or a class of behaviors resulting in direct physical harm 
to the person exhibiting the behavior, restricting spatial 
and temporal topographies, and occurring at a reliable, 
observable rate (Schroeder, 1991; Schroeder, Rojahn,
Mulick, & Schroeder, 1990; Fee & Matson, 1992).
Self-hitting, hair-pulling, self-scratching, and 
self-gouging of eyes, ears, mouth, throat, nose, and rectum 
are frequently reported types; however, head-banging and 
self-biting are the most common forms of SIB among persons 
with mental retardation (Thompson, Axtell, & Schaal, 1993) . 
SIB occurs along a severity continuum from repetitive face 
rubbing to life-threatening head banging (Fee & Matson,
1992) . Unlike suicidal gestures, self-neglect, and 
self-mutilation, SIB occurs without the apparent intent of 
self-harm.
SIB occurs in 6.5% of people with mental retardation 
living in community settings and in 15.4% of those living 
in public residential settings, with 20,000 to 25,000 
displaying severe SIB (Thompson et al., 1994). SIB occurs 
in 40% of hospitalized children with psychotic diagnoses
7
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and in 7% to 30% of individuals with neur©developmental 
delays (Sandman, Hetrick, Taylor, & Chicz-DeMet, 1997). 
People with SIB are costly to serve. Time spent managing 
SIB accounts for 62% more staff time than does aggressive 
outbursts (Silverstein, Olvera, & Schalock, 1987) .
SIB is viewed as an exacerbated form of stereotyped 
behavior, with a common etiologic base but marked 
idiosyncratic differences with regard to topography, 
severity, frequency, and duration (Baumeister & Forehand, 
197 3). In its most severe form, SIB may result in extensive 
tissue damage, fractures, amputation, and death, and is 
considered the most severe behavior problem encountered by 
service providers (Mace, Lalli, & Shea, 1992).
Hyperactivity
Hyperactivity refers to behavior that is excessive, 
situationally inappropriate, or specific to a psychological 
syndrome such as Attention Deficit Hyperactivity Disorder 
(ADHD) and may be associated with conditions including 
anxiety, mania, schizophrenia, hysteria, hypoglycemia, 
hyperthyroid, and akathisia (Coe & Matson, 1993; Chandler, 
Gualtieri, and Fahs, 19 88). Differential diagnosis is 
difficult for individuals with profound or severe mental 
retardation, who characteristically exhibit attention 
deficits and activity excesses. A multimodal assessment, 
combining psychiatric, pharmacological, and direct 
observation techniques, is required with this population 
(Coe & Matson, 1993). Biochemical substrates assumed to
8
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underlie hyperactivity include the catecholamines, 
dopamine, and norepinephrine; however, the primary evidence 
for these theories rest in the action of drugs used to 
treat hyperactivity on these transmitter systems 
(Baumeister & Sevin, 1990).
Hyperactivity has generally been considered an 
essential component of ADHD; however, ADHD has undergone a 
number of changes in the Diagnostic and Statistical Manual 
of Mental Disorders (DSM). Identified as hyperkinetic 
reaction of childhood in DSM-II and attention deficit 
disorder in DSM-III, the disorder continues as attention 
deficit/hyperactivity disorder in DSM-IV, and the criteria 
for the disorder also includes either symptoms of 
inattention or hyperactivity.
Behavioral Treatment Approaches
Interventions for persons with mental retardation have 
centered on behavioral approaches with less emphasis on 
psychiatric diagnosis (Fisher, Piazza, & Page, 1989). 
Behavioral theories of disruptive behaviors maintain that 
the aberrant behaviors frequently associated with 
individuals with mental retardation are learned behaviors 
maintained by their consequences (Beier, 1964; Gardner & 
Sovner, 1994). Carr's (1977) review of the SIB literature 
suggested three operant hypotheses related to the 
development and maintenance of self-injury: (a) socially
mediated positive reinforcement, (b) socially mediated
9
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negative reinforcement, and, (c) sensory or automatic 
reinforcement.
Socially mediated reinforcement is when consequences 
delivered by another person strengthen a behavior. An 
example of socially mediated positive reinforcement is a 
statement of concern or reprimand resulting in a behavioral 
increase when presented following incidents of SIB.
An example of socially mediated negative reinforcement 
is the removal of an instructional activity as a 
consequence for disruptive behavior, which results in 
increased rates of behavior on subsequent instructional 
presentations. Thus, a care provider responding to SIB by 
removing a task or instruction may inadvertently reinforce 
the behavior, and SIB becomes functional in escaping 
ongoing aversive or unattractive activities or avoiding 
anticipated unpleasant situations (Gardner & Sovner, 1994).
Automatic reinforcement refers to situations where 
behavior generates its own reinforcement. Common labels for 
automatically reinforced disruptive behaviors include 
stereotypy, self-stimulation, and repetitive mannerism 
(Vollmer, 1994). An example of automatic positive 
reinforcement is when eye poking automatically stimulates 
the area around the eye. Automatic negatively reinforced 
behaviors result in response-contingent termination of 
aversive physiological conditions (e.g., ear or tooth ache, 
chronic dermatitis). Examples include scratching the skin
10
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
after an insect bite or ear-hitting when experiencing ear 
infections (Cataldo & Harris, 1982) .
Behavioral Assessments and Treatments
Initially, within the field of developmental 
disabilities, interventions were developed and applied 
based on behavior topography rather than function. Clinical 
assumptions about the underlying psychopathology of an 
exhibited behavior (SIB) were made and behavioral or 
psychopharmacological treatments were prescribed 
accordingly. Treatments were applied sequentially in 
accordance with a least-to-most restrictive method and/or 
by reviewing the literature for previous treatment 
applications with that target behavior form or topography 
(Thompson, et al., 1993).
The current dual behavior assessment process includes
(a) a topographical inventory of individual behavioral 
strengths and deficits and (b) functional analysis of 
behavior excesses (Sturmey, 1996). Standardized checklists 
and scales, observations, and interviews are used to 
identify behavioral strengths and weaknesses (Hamilton & 
Matson, 1992). Topographical assessments are used in 
group-based research and clinical outcome studies (Sturmey,
1996). The second level of behavior assessment is 
prescriptive, functional assessment to identify the 
controlling contingencies that will lead to appropriate and 
effective intervention selection (Madle & Neisworth, 199 0; 
Rojahn & Sisson, 1990). Current trends are to use
11
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functional analysis to incorporate more sophisticated 
rearrangements of existing consequences into natural 
counteracting interventions (Mace et al., 1992).
Functional Analysis
Current functional analysis procedures are designed to 
either identify or rule out social contingencies. Within 
the protocol, conditions are deliberately manipulated to 
expose participants to particular antecedents and 
consequences. Consistently high aberrant-behavior rates in 
a test condition suggest that a functional relationship 
exists (Iwata, Dorsey, Slifer, Bauman, & Richman,
19 82/1994) . Specifically, antecedent and consequent events 
particular to that condition are considered to be 
functionally related to the problem behavior.
Iwata et al. (1982/1994) empirically tested Carr's 
(1977) operant hypotheses in the assessment of SIB for nine 
individuals. Two types of contingencies (e.g., positive and 
negative reinforcement) and two sources of stimulus 
delivery or removal (e.g., socially mediated versus 
automatic) made up the four standardized components used to 
suggest different types of behavioral interventions for 
SIB. The experimental conditions were (a) academic demand,
(b) reprimand, and (c) alone in an austere environment to 
determine if SIB persisted in the absence of social 
reinforcement. The control or play condition involved no 
instructional demands, noncontingent attention, and free 
access to leisure materials. Results demonstrated that the
12
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functions of SIB were idiosyncratic across individuals. For 
example, SIB appeared to serve a positive reinforcement 
function for participants who engaged in increased rates of 
SIB during the reprimand condition. Higher rates of SIB 
during the demand condition suggest a negative 
reinforcement function. Finally, some participants 
exhibited high levels of SIB in the alone condition, 
suggesting that SIB was not maintained by social 
consequences.
In summary, the functional analysis protocol 
deliberately manipulates test conditions to expose 
participants to particular antecedents and consequences. 
Consistently high aberrant-behavior rates in one or more 
test conditions suggest that a functional relationship 
exists (Iwata et al., 1982/1994). Specifically, antecedent 
and consequent events particular to the condition are 
considered functionally related to the target behavior and 
incorporated into behavior reduction interventions.
Numerous other researchers have demonstrated the 
utility of functional analysis. For example, Sasso et al. 
(1992) used the same basic protocol to demonstrate the 
applicability and utility of functional analyses of 
disruptive behaviors (aggression and inappropriate 
language) in school settings with two children with autism. 
Fisher et al. (1989) and Northup et al. (1999; in press) 
have used functional analysis to evaluate the interaction
13
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effects of concurrent behavioral and pharmacologic 
interventions.
Function-related Interventions
The goal of functional analysis is to match the 
intervention to the results of the functional assessment by 
utilizing existing environmental conditions. Functional 
analysis may also suggest eliminating some common 
treatments. The three guidelines for incorporating 
functional analysis results into treatment design are 
(a) eliminate or weaken reinforcers identified as following 
inappropriate behaviors, (b) provide the same reinforcer 
for alternative, appropriate behaviors, and (c) use 
antecedent manipulations identified in functional analysis 
(e.g., appropriate task or curriculum, instructional 
modifications). Thus, once a behavioral function is 
identified it may become possible to eliminate reinforcing 
contingencies (extinction), present reinforcement for more 
appropriate alternative behaviors (differential 
reinforcement), or alter the efficacy of the reinforcer 
maintaining the problem behavior (establishing operations).
Pharmacotherapy 
Pharmacotherapy or psychopharmacology for individuals 
with mental retardation primarily involves psychotropic and 
psychoactive medications used to manage behavior considered 
to be harmful to the individual (SIB), to others 
(aggression), or to control behavior that may interfere 
with training or education (e.g., hyperactivity,
14
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stereotypy). Less frequently, medications are also used to 
treat intellectual impairments or emotional disorders 
(Baumeister & Sevin, 1990). Psychotropic medication is any 
substance administered for the purpose of producing 
behavioral, emotional, or cognitive changes; a psychoactive 
drug is any agent that has such effects regardless of the 
purpose of prescribing the medication (Aman & Singh, 1988) .
Research and clinical prescription of psychotropic 
medications for persons with mental retardation differ from 
other areas of neuropsychiatry. Typically, little 
consideration is given to the actions of the neural 
substrates that underlie the created conditions. 
Psychopharmacological treatment in the field of mental 
retardation is directed more toward suppression of 
behavioral symptoms than matching known agents to 
well-defined disorders as in adult psychiatry (Baumeister & 
Sevin, 1990; Aman & Singh, 1991). Pharmacologic treatments 
focus on the target behavior and generally serve 
suppressive functions (Thompson, et al., 1993). Thus, drugs 
used to control the behavior of persons with mental 
retardation without any clear theoretical rationale, may be 
countertherapeutic (Baumeister & Sevin, 199 0).
Commonly Used Medications
Most drugs prescribed for behavior disturbance and 
psychopathology in individuals with mental retardation have 
been borrowed from other clinical populations. Before 1950, 
hypnotic drugs (e.g., chloral hydrate and paraldehyde) were
15
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the primary pharmacological behavior management agents used 
with individuals exhibiting mental retardation. These 
medications were used as sleep-provoking medications at 
night and to sedate persons displaying aberrant behavior 
during the day (Thompson, Hackenberg, & Schaal, 1990;
Schaal & Hackenberg, 1994). In 1955, Blair and Herold used 
chlorpromazine for behavior problems exhibited in people 
with mental retardation. Phenothiazines very quickly, 
became the treatment of choice for institutionalized people 
displaying agitation, aggression, or SIB. The use of modern 
psychiatric medications to treat behavior disturbance among 
individuals with mental retardation subsequently grew 
rapidly for two decades (Thompson et al., 1990).
The neuroleptics established a pattern of the 
treatment for severe behavior disturbances in individuals 
with mental retardation that has been replicated by 
virtually every available psychotropic medication. 
Generally, the goal is to reduce aggressive behavior, SIB, 
agitation, property destruction, and stereotypies (Schaal & 
Hackenberg, 1994).
Patterns of Drug Use
Persons with mental retardation are among the most 
medicated population in our society (Aman & Singh, 1991). 
From 30% to 50% of institutionalized individuals with 
mental retardation are medicated. Between 25% and 35% 
typically receive anticonvulsant medication. Thus, 50% to 
67% of the residential population with mental retardation
16
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are receiving either a psychotropic or anticonvulsant 
medication (Aman & Singh, 1991). The most often prescribed 
medications within institutions include psychotropic drugs 
(thioridazine, chlorpromazine, diazepam, haloperidol, 
mesoridazine, and hydroxyzine) and antiepileptic drugs 
(phenobarbital, phenytoin, primidone, carbamazepine, and 
sodium valproate). Stereotypies, aggression, and SIB are 
frequently treated with neuroleptics, anticonvulsants, 
antidepressant and antimanic drugs, anxiolytic drugs 
(benzodiazepines), and stimulant drugs.
Baumeister, Todd, and Sevin (1993) reviewed more than 
three dozen studies and reported prevalence differences for 
persons with mental retardation residing in institutions 
and community or school based settings reflect varying 
degrees of handicap and different rates of aberrant 
behavior. As noted in Table 1 below, the mean prevalence of 
psychotropic medication use in persons with mental 
retardation varied greatly in relation to the type of 
residential placement.
Table l. Psychotropic Prevalence: Mean Percentage for 
Persons with Mental Retardation
Drug Institutions Supported Living Schools
All psychotropics 57 .4 41.4 22 .8
Anticonvulsants 31.6 21.6 15 .4
Neuroleptics 31.8 19 .0 4.4
Antidepressants 2.9 5.0 0.9
Anxiolytics 8.5 3.8
Sedative/hypnotics 6.0 2.6
Stimulants 0.5 0.5 0.1
The high prevalence of anticonvulsant use is related to the 
high incidence of convulsive disorder and the use of this
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drug class to manage aberrant behavior in persons with 
mental retardation independently of their anticonvulsant 
effect (Beaumeister et al., 1993).
Tu and Smith (1983) noted the six most common problems 
and prevalences among medicated individuals with mental 
retardation are as follows: aggression (29%), hyperactivity 
(24%), SIB (19%), excitability (12%), screaming (10%), and 
anxiety (8%). Hyperactivity was the strongest predictor for 
neuroleptic use in community residential facilities; 
violent or destructive behavior was the strongest predictor 
for neuroleptic use in institutions (Intagliata & Rinck,
1985).
Methodological Considerations
Minimal requirements for a scientifically controlled drug 
study are as follows: placebo control, random assignment of 
subjects (group comparison designs), adequate baseline and 
reversal phases (single-subject or within-subjects 
designs), double-blind observations or evaluations of drug 
effects to minimize bias, standardized doses, direct or 
standardized (valid, reliable) measures of drug effect 
(behavior change), and appropriate use of inferential 
statistics (group designs) or visual analysis 
(single-subject designs) to measure drug-related changes 
(Sprague & Werry, 1971; Aman & Singh, 1988, 1991;
Baumeister & Sevin, 1990; Thompson et al., 1990; Singh, 
Singh, & Ellis, 1992; Schaal & Hackenberg, 1994) .
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Pre-197 5 studies in the field of mental retardation 
violated one or more of the above mentioned criteria and 
were clearly inferior to work occurring with other clinical 
populations (Aman & Singh, 1988). The difficulties in 
working with persons with developmental disabilities make 
it challenging to conduct elaborate research. The number of 
adequately controlled studies have consistently increased 
during the past twenty years (Aman & Singh, 1988;
Baumeister et al. 1993). Additionally, studies are 
appearing with specific indications for the various 
psychotropic drugs prescribed for persons with mental 
retardation (Fisher et al., 1989; Johnson, Handen,
Lubetsky, & Sacco, 1994; Aman, et al., 1997; Christian, 
Kerr, Sutphin, & Poling, 1997).
Well designed studies in the field of mental 
retardation (a) describe medication effects on specific 
behaviors, (b) separate the effects of different drugs,
(c) separate the drug effects for participants with mental 
retardation from other individuals (Baumeister et al.,
1993), and (d) control for environmental variables. Aman 
and Singh (1988; 1991) urge medication trials be free of 
other drug confounds and be compared to alternative 
interventions.
Measuring Dose-Response Relationships
The dose-response relationship is the orderly 
relationship between the quantity of a drug and the 
magnitude of effect. Psychopharmacological research
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measurement techniques commonly used to measure drug 
effects require adjustments for the cognitive and 
behavioral deficits of persons with mental retardation. 
Baumeister and Sevin (199 0) are critical of studies that 
lump disruptive behaviors and provide only a global measure 
of change (e.g., percent improved). Drugs may have 
differential effects on a given behavior or classes of 
behavior at different doses. Singh et al. (1992) recommend
studies include measures of collateral behaviors (e.g., 
learning, adaptive and maladaptive behaviors) as well as 
dosage effects to determine dose-dependent relationships.
Global impressions. Global impressions are ratings of 
overall behavior change or clinical improvement based on 
the rater's subjective impressions of the participant (Aman 
& Singh, 1988; Baumeister & Sevin, 1990). Although useful 
as general indicators of change from the subjective opinion 
of service providers, global impression measures lack 
objective criteria against which changes can be judged and 
should not be used in isolation. For example, teachers will 
rate changes in learning and cognition more positively than 
support workers in custodial settings (Baumeister & Sevin, 
1990) .
Direct behavioral observations. Direct behavioral 
observations are less prone to bias but have only recently 
become common in psychopharmacological research with 
persons with mental retardation (Aman & Singh, 1988).
Within the direct observation method, principles of applied
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behavior analysis are used to select and define target 
behaviors, complete initial descriptive analyses, and 
sample a broad range of maladaptive and adaptive behaviors 
using standardized procedures of data collection (Singh & 
Beale, 19 86).
Rating scales. Rating scales have been the major 
assessment procedure of behavior change in pediatric 
psychopharmacology but have less prevalence in studies with 
individuals with mental retardation (Aman & Singh, 1988). 
There are numerous scales designed for measuring behavior 
change in developmentally delayed populations, but most 
have not been used in psychopharmacological investigations 
(Aman & Singh, 19 88). Only a small number of scales normed 
with this population have demonstrated adequate 
psychometric properties in psychopathological assessment 
(Aman & Singh, 19 88).
Learning measures. Learning measures are indices of 
cognition and learning that are recommended for inclusion 
in the assessment of drug effects (Sprague & Werry, 1971; 
Aman & Singh, 1988) . IQ tests, achievement tests, 
curriculum measures, vocational training tasks, and 
performance tests for attention or dexterity have been used 
as learning measures. Assessing drug-related change in 
learning performance is difficult with a population having 
major learning and cognition deficits. Aman and White 
(19 86) reviewed a number of tasks (e.g., operant 
conditioning and discrimination learning tasks) that appear
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to have some utility as learning measures in 
psychopharmacological research. In general, IQ and 
achievement tests appear to be the least sensitive to 
medication effects, and the literature suggests performance 
tests are most likely to be effected by medication (Werry & 
Sprague, 1972; Aman & Singh, 1988).
Physiological measures. Dependent measures in 
psychopharmacology research generally require the 
participant's active involvement. Functional level, 
associated physical impairments, and behavior problems may 
preclude compliance for persons with mental retardation. 
Physiological measures are an alternative method of 
assessing medication effects. Aman and White (19 86) 
recommend physical measures of motor coordination, 
physiological measures (e.g., galvanic skin response, heart 
rate), and play or activity measures (e.g., mechanical 
transducers) as useful tools.
Behavior Pharmacology 
Behavior pharmacology recognizes the significance of 
pharmacological variables (e.g., dose) as determinants of 
drug action, but places primary emphasis on behavioral and 
environmental variables that have been demonstrated to 
modulate drug effects.
To understand the mechanisms of a drug's action in 
changing behavior, it may be advantageous to search for 
behavior mechanisms of drug action. A behavioral mechanism 
of action describe a drug's behavioral effects in terms of
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alterations made on environmental variables normally 
regulating that behavior (Thompson & Schuster, 196 8; 
Thompson, 1984). Specifying the behavioral mechanisms 
responsible for an observed effect involves (a) identifying 
the environmental variables that typically regulate the 
behavior in question, and (b) characterizing the manner in 
which the influence of those variables is altered by the 
drug (Thompson, 1981). For example, a drug could weaken the 
effectiveness of known rewards or reinforcers, or diminish 
the efficacy of punishing events in suppressing destructive 
or aggressive behavior (Northup, et al., 1997).
A Functional Approach in Medication Studies
Schaal and Hackenberg (1994) criticize studies that 
select participants based on topographical features of the 
problem behavior (e.g., self-hitting) without considering 
the function of the behavior. These authors recommend a 
pharmacotherapeutic approach that includes functional 
analyses of behavior disorders with appropriate 
consideration of the pharmacological agent and 
developmental variables involved.
Thompson et al. (1993) recommend an analysis of the 
behavior mechanism of drug action in drug efficacy studies. 
For example, four classes of behavioral mechanisms of drug 
action relevant to SIB include (a) neuroleptic reduction of 
SIB when the behavior problem is maintained by terminating 
conditioned negative reinforcers, (b) neuroleptic reduced 
control of reinforcing stereotypic stimulation, (c) opiate
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antagonist blocking of the reinforcing effects of 
endorphins binding to the opiate receptor, and (d) the 
benzodiazepine exacerbation of SIB with the antisuppressive 
effects diminished in strength by the natural painful 
results (Thompson et al., 1994). Thompson et al. (1993) 
advocates a tri-dimensional analysis of SIB that includes 
establishing the temporal pattern and repetitiveness of the 
SIB, the degree it is under external environmental control, 
and the degree pain serves as a maintaining event.
Stimulant Medications and Mental Retardation
CNS stimulant medications, such as methylphenidate 
(MPH) or Ritalin, dextroamphetamine (dexedrine), and 
pemoline (cylert), are the medications of choice for ADHD. 
MPH is the most prescribed stimulant medication and 
imipramine (Tofranil) and fenfluramine are the most 
prescribed for stimulant nonresponders (APA, 1994).
Although it shares a similar pharmacologic profile with 
amphetamine, therapeutic doses of MPH have a more marked 
effect on cognitive functions than physical or motor 
activities.
Reported side effects of stimulant medications include 
stomach ache, headache, depressed appetite, insomnia, 
dizziness, and tics. Ahmann et al. (1993) systematically 
addressed the frequency and severity of associated 
stimulant-related side effects and found only four symptoms 
(stomach ache, headache, decreased appetite, and dizziness) 
were reported to increase over baseline with stimulant use.
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Nolan and Gadow (1997) studied the differential effects of 
doses of MPH (0.1 to 0.5 mg/kg) and placebo in normal-IQ 
children with ADHD and chronic motor tics. Dramatic 
improvement was noted in 32% of the 34 children receiving 
the 0.5 mg/kg dose and no increases in tics were noted. 
Handen, Feldman, Gosling, Breaux, and McAuliffe (1991) 
found stimulant use induced motor tics (11.1%) and social 
withdrawal (7.4%) in 27 children dually diagnosed with 
mental retardation (IQs 48 to 74)and ADHD.
Dosage
MPH is a mild CNS stimulant and is manufactured in 
doses of 5, 10, 20 mg, and sustained release, 20 mg 
tablets. The drug has a relatively brief half-life with the 
behavioral effects of MPH peaking approximately 1 ^ hours 
after ingestion, and decreasing gradually until they 
disappear approximately 2 hours later. The time-response 
curve of MPH indicates that the behavioral effects increase 
for the first two hours after administration, and decrease 
in what is similar to a bell-shaped curve (Pelham, Jr.,
1993). MPH is expected to be eliminated entirely from the 
body within 24 hours after ingestion. Some studies suggest 
that sustained-release MPH may be less effective in the 
first hours after administration. Thus, short-acting MPH is 
prescribed more often than the sustained-release dose 
(DuPaul, Barkley, & McMurray, 1991; Barkley, 1989).
Body weight (mg/kg) and blood levels are not always 
accurate predictors of dose-response to stimulant
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medication. Additionally, idiosyncratic responses occur
(a) across behaviors for the same child and (b) between 
children of the same weight, height, and gender for similar 
behavior (DuPaul & Barkley, 1993). A particular dose may 
increase a child's academic performance, but fail to make 
substantial decreases in disruptive classroom behaviors 
(Sprague & Sleator, 1977). Therefore, individualized 
evaluations of MPH effects are recommended.
MPH Effects across Behavioral Classes
The idiosyncratic effect of MPH across behavior 
classes (e.g., academic performance, attention, social 
interaction) has immediate and long-term implications when 
choosing behaviors to be targeted in assessment and 
intervention (Rapport & Kelly, 1991). Sprague and Sleator 
(1977) conducted the seminal study assessing multiple 
behaviors (social behavior, learning performance) across 
different doses of stimulant medication (placebo, 0.3 
mg/kg, and 1.0 mg/kg) by using the Abbreviated Conners 
Teacher Rating Scale (ACTRS) and a picture recognition task 
at three levels of increasing difficulty (3, 9, and 15 
pictures). Results indicated that learning performance was 
optimal at the lower MPH dose level but teacher ratings 
were optimal at the higher MPH dose level.
A series of clinic-based studies evaluated the effects 
of four doses of MPH (5, 10, 15, and 20 mg) and a placebo 
on the school and clinic behaviors of children diagnosed 
with ADHD (Rapport & Kelly, 1993). Weekly, clinic measures
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were compared to three classroom observations. Clinic 
measures included the Continuous Performance Task (CPT), 
the Matching Familiar Figures Test (MFFT), and the Paired 
Associate Learning (PAL) task. Classroom measures included 
academic performance, on-task behavior, and teacher ratings 
of overall classroom behavior. The classroom measures were 
highly sensitive to both overall and between dose effects 
while most of the clinic measures were found to be 
insensitive in detecting overall and between dose MPH 
differences. The MFFT did indicate overall and between dose 
differences with the 15 mg dose when compared to the lower 
doses (5 and 10 mg) and placebo (Rapport & Kelly, 1993) .
Rapport, Stoner, DuPaul, Birmingham, and Tucker (19 85) 
used a triple-blind, placebo-controlled, crossover 
experimental design to evaluate the performance of children 
receiving three dosages of MPH (5, 10, and 15 mg) on the 
clinic-administrated PAL measures and multiple, 
school-related behaviors (teacher ratings, on-task, work 
completion, and accuracy). An ANCOVA with repeated measures 
computed on all dependent variables indicated
(a) significant dose effects on teacher ratings, percent 
on-task, and academic accuracy, (b) significantly higher 
teacher ratings for the placebo condition compared to all 
medication conditions, and (c) significant differences in 
all dependent measures, except the PAL task, with higher 
doses typically effecting the most change. When the PAL
27
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
task results were analyzed separately, the children showed 
response to medication dosage.
Rapport, DuPaul, Stoner, and Jones (19 86) evaluated 
the utility of classroom observations and the CPT in 
detecting dose-response effects of three levels of MPH (5, 
10, 15 mg) in a double-blind, placebo-controlled crossover 
design. CPT variables included CPT omission and commission 
errors and percent of on-task behavior, completed 
assignments, correctly completed assignments, and teacher 
ratings. Statistical analysis indicated significant overall 
effects for all dependent measures; however, analyses at 
the individual level showed an idiosyncratic response 
across children. The individual responses to MPH were task 
specific for some children.
Methodology in Stimulant Medication Evaluations 
General Assessment Procedures 
The ADHD-stimulant medication efficacy studies have 
been prominent in developing a systematic behavioral 
investigation to determine drug-behavior interaction. In 
clinical practice, the rationale for dosage selection is 
usually not determined in an objective manner (Gadow,
Nolan, Paolicelli, & Sprafkin, 1991).
Physicians typically use a physical exam and a 
parental interview that stresses history and nature of the 
presenting symptoms (Barkley, 1987; DuPaul & Barkley, 1993; 
Gulley & Northup, 1997) . A single office visit will often 
generate a diagnosis and a prescription for stimulant
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medication at the lowest dose, to be titrated upward as 
indicated by parent reports at subsequent visits. The 
traditional prescriptive approach to stimulant medication 
fails to recognize the complexity of stimulant medication 
effects and the individual needs of the children for whom 
the medication is prescribed. Pelham, Jr., (1993) cautions 
that the traditional prescriptive practice may result in 
many children either receiving an inappropriate dose or 
being prescribed stimulant medication when it is 
contraindicated.
Recent research indicates most of the common 
assessment procedures do not adequately evaluate all the 
behavioral areas that stimulant medication affect (DuPaul & 
Barkley, 1993; Gulley & Northup, 1997). Behavioral 
assessment procedures (e.g., direct observations, academic 
performance measures, behavior ratings across raters) are 
adapted to stimulant medication assessments that require 
measures of behavior change, dosage effects, social 
validity, and convergent validity of observational measures 
with data from other sources (Pelham, Vodde-Hamilton, 
Murphy, Greenstein, & Vallano, 1991). The more common 
behavioral assessment procedures and traditional laboratory 
tests of attention and impulsivity are reviewed below. 
Laboratory Assessments
Clinical evaluations of dose response use general 
performance tests that assess impulsivity and attention.
The measures are considered sensitive to medication
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effects; however, predictive validity related to the 
child's actual classroom behavior is low. The measures do 
not detect changes in the multiple areas of functioning 
that may be affected by stimulant medication (Rapport & 
Kelly, 1993).
Continuous Performance Task (CPT; Rosvold. Mirskv. 
Sarason. Bransome. & Beck. 19 56). The CPT is a widely used 
laboratory measure of the vigilance or attention span of 
children with ADHD. The child presses a button when a 
previously specified number or letter appears in a rapidly 
presented numerical or letter sequence. The test yields 
scores of sustained attention (the number of correct 
responses, the number of missed stimuli or omission 
errors), and a score of impulsivity (the number of 
responses to inappropriate stimuli or commission errors).
Gordon Diagnostic System (GPS: Gordon. 1983). The GDS 
is a CPT variation that uses a computerized, 9 -minute 
vigilance task. The child presses a large button after 
specified numerical sequences. The GDS has satisfactory 
normative data and test-retest reliability. It is 
considered sensitive to moderate to high doses of stimulant 
medication and discriminates ADHD from non-ADHD children 
(Barkley, 1990).
Matching Familiar Figures Test (MFFT: Kagan. 1966).
The MFFT is the most widely used clinical measure of 
impulsivity. The child identifies one correct stimulus 
picture from six similar variations during 12 trials. The
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test generates a total error score (number of incorrect 
identifications) and a latency score (mean time between the 
presentation of a stimulus card and the subject's initial 
response). Some studies have reported conflicting or 
negative results in regard to stimulant drug effects or 
failed to discriminate between children with and without 
ADHD (Barkley, 1990) .
Delay Task (Gordon. 1983). The Delay Task is an 
8-minute measure of impulsivity that incorporates the GDS 
program with a differential reinforcement of low rates 
paradigm. More points are earned if the child successfully 
delays button pressing following presentation of the 
specified sequence. The Delay Task has normative data and 
discriminates between ADHD and non-ADHD children; however, 
it may not be sensitive to stimulant drug effects and 
correlates poorly with parent and teacher ratings (Barkley, 
Fischer, Newby & Breen, 1988; Barkley, 1990).
Teacher's Self-Control Rating Scale (TSCRS: Humphrey. 
1982). The TSCRS is a 15-item teacher rating scale that 
assesses self-control. Teachers rate behaviors on a 5-point 
Likert scale from 1 (never happens) to 5 (often happens). 
The scale yields scores for a behavioral/interpersonal 
factor score, a cognitive/personal self-control factor, and 
total self control. The TSCRS has demonstrated adequate 
psychometric properties and positive correlations with 
naturalistic behavioral observations (Rapport et al., 1985; 
Humphrey, 1982).
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Paired Associate Learning (PAL). The PAL task was 
developed to determine optimal stimulant dose and stimulant 
responsiveness (Rapport et al. , 1985). A series of familiar 
animal picture cards are presented, assigned specific zoo 
numbers, and shuffled. The child verbally matches the 
animal card with the appropriate zoo number from 10 trials. 
Academi c
Academic measures of stimulant medication effects must 
be administered repeatedly across doses. Standardized 
academic achievement tests are not sensitive to the 
productivity and accuracy changes that occur in repeated 
medication trials (DuPaul & Barkley, 1993).
Permanent work products. Academic performance response 
to medication effects is measured with permanent work 
products (e.g., academic productivity and accuracy ratings 
of routine, daily, teacher-assigned tasks). Academic 
productivity measures include the number of academic tasks 
completed (e.g., number of problems worked, number of words 
read) or the number of units produced. Accuracy is the 
number of items worked or completed correctly (percent 
correct).
Curriculum based measurement (CBM). CBM appears to be 
an effective measure of academic performance in stimulant 
medication trials (Gulley and Northup, 1997; Stoner, Carey, 
Ikeda, & Shinn, 1994). CBM uses a behavioral-assessment 
perspective to evaluate academic performance in reading, 
math, spelling, and written expression (Shinn, 1989). CBM
32
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
measures make direct and repeated assessments of a child's 
academic performance and use graphed results as time series 
data in ongoing decision making. CBM measures have compared 
favorably with teacher ratings on the Academic Performance 
Rating Scale (APRS; DuPaul, Rapport, & Perriello, 1991; the 
Child Attention Problems scale (CAP; Barkley, 1990), and 
the Side Effects Rating Scale (SDERS; Barkley, 1990).
Social Skills
Social difficulties and poor peer relationships are 
among the most pervasive problems children with ADHD 
experience and are considered significant predictors of 
long term maladjustment (Hoza, Pelham, Jr., Sams, &
Carlson, 1992). The majority of medication studies have 
concentrated on authority rather than peer social 
relationships (Hinshaw, 1991; Klorman et al., 1988). Thus, 
most studies assess changes in the child's social skills 
with the parent or teacher (Hinshaw, 1991; Klorman et al., 
19 88), and a few studies have targeted social skills with 
peers (Pelham et al., 1987; Hinshaw, Henker, Whalen, 
Erhardt, & Dunnington, 1989; Gulley & Northup, 1997; 
Northup, Jones et al., 1997).
Hinshaw et al. (1989) evaluated the effects of 
stimulant medication on the noncompliance, aggressive, and 
social behaviors of 25 boys with ADHD with two doses of 
MPH. The nonsocial category was added to measure decrease 
in sociability or the zombie effect teachers or parents 
attribute to an overmedicated child. Main effects were
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found for noncompliance and aggression during the 
medication trials, but no effects were found for prosocial 
or nonsocial behavior.
MPH may be effective in decreasing negative 
verbalizations, conduct problems, and negative peer 
interactions for some children with ADHD (Pelham & Bender, 
1982; Pelham & Hoza, 1987). Most studies have combined 
medication with various behavioral treatments. Group 
studies of children with ADHD and average intelligence have 
found that behavioral treatments in combination with low 
doses of MPH are more effective than either intervention 
alone (Carlson, Pelham, Milich, & Dixon, 1992; Pelham 
Milich, & Walker, 19 86). The degree to which these group 
studies characterize the response of individual children to 
these interventions is not known. More research is needed 
to determine the separate and combined effects that 
medication and behavioral interventions may have on the 
children's social and classroom behaviors (Blum, Mauk, 
McComas, & Mace, 1996; Gulley & Northup, 1997; Northup et 
al., 1999; in press). Current literature is limited by the 
narrow range of studies, the use of different doses of 
medication, and the lack of systematic dose manipulation 
(Cunningham, Siegel, & Offord, 19 85).
Multimethod Stimulant Medication Assessments 
School Based Medication Evaluation (SBME)
SBME (Gadow, 1991) is a standardized observation 
method that uses behavior rating scales and direct
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observations of child behavior to evaluate medication 
effects. SBME uses a target behavior response rate at 
placebo and each level of medication to establish a minimal 
effective dose for each child. The protocol includes (a) a 
parent and teacher rating scale, (b) a stimulant side 
effects checklist, (c) direct observations of disruptive 
behaviors with the Classroom Observation Code (Abikoff & 
Gittelman, 19 85), and (d) direct observations of social 
behavior with the Code for Observing Social Activity (COSA; 
Sprafkin & Gadow, 19 87) .
Other Multimethod Approaches
Fischer and Newby (1991) developed a clinical protocol 
to assess medication effects for children with ADHD using
(a) a double blind procedure and a weekly randomized 
rotation of medication status at placebo and low (0.2 mg/kg 
BID) and high (0.4 mg/kg BID) doses of MPH, (b) an initial 
clinical evaluation that included the Child Behavior 
Checklist (CBCL; Achenbach & Edelbrock; 1993), (c) weekly
parent and teacher rating scales, and (e) weekly laboratory 
measures (the Multi-Choice Reaction Timer, the GDS 
vigilance task, and a restricted academic task). Weekly 
parent rating scales included the Home Situations 
Questionnaire (HSQ; Barkley, 1991), the Conners' Parent 
Rating Scale-Revised (Goyette, Conners, & Ulrich, 1978), 
and the Side Effects Rating Scale. Weekly teacher rating 
scales were the School Situations Questionnaire (SSQ; 
Barkley, 1991), the Conners' Teacher Rating Scale-Revised
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(CTRS-R; Goyette et al., 1978), and the Side Effects Rating 
Scale. The protocol yields measures of reaction time, 
sustained attention, impulsivity, and a variety of child 
behaviors during the restricted academic situation.
Recent single-subject studies with children with ADHD 
have extended the Fischer and Newby (1991) protocol by 
developing a comprehensive assessment procedure across 
multiple behavior measures to determine (a) an optimal dose 
of stimulant medication, if any, (b) medication effect 
variations across doses, and (c) medication effects across 
child behaviors.
Gulley and Northup (1997) used a double-blind, 
placebo-controlled, single-subject experimental design to 
evaluate the effects of three doses of MPH (low, moderate, 
and high) across the behavioral domains of academic 
performance, classroom behavior, attention, social 
interactions, and teacher ratings of child behavior.
Results suggested CBM and direct behavior observations were 
sensitive to medication response for all students. Northup 
et al. (1999; in press) used a double-blind, 
placebo-controlled, multielement design and functional 
analysis assessments within the classroom setting to 
demonstrate the differential effects that stimulant 
medication may have on student academic and behavioral 
performance with and without contingency management 
interventions in place (e.g., praise, reprimands, time 
out). These studies strongly indicate that classroom
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interventions can be enhanced with stimulant medication; 
however, to be effective the treatments require thorough 
behavioral assessments or functional analyses.
Assessing Stimulant Medication Effectiveness for 
Individuals with Mental Retardation
Despite the demonstrated efficacy for treating 
hyperactivity in children with ADHD, stimulants are not a 
prevalent medication treatment in residential settings for 
individuals with developmental disabilities (Aman & Singh, 
1991; Chandler et al., 1988). Early studies involving 
people diagnosed with mental retardation suggested 
stimulant medications were effective in reducing 
hyperactivity and improving intellectual functioning and 
performance on psychological tasks (Bell & Zubek, 1961; 
Morris, MacGillibary, & Mathieson, 1955). Subsequent 
investigations failed to clearly support the therapeutic 
efficacy of stimulants (Aman, 1982; Aman & Singh, 1982; 
Berkson, 196 5; Davis, Sprague, & Werry, 1969; McConnell, 
Cromwell, Bialer, & Son, 1964; Shafto & Sulzbacher, 1977). 
Due to the potential for MPH to precipitate irreversible 
tics in hyperactive children with Tourette's disorder and 
seizure activity in hyperactive children with autism, 
physicians have been cautious in prescribing MPH for 
children with developmental disabilities (Klein, Gittelman, 
& Quitkin, 1980; Schaal & Hackenberg, 1994).
Most authorities currently agree that the probability 
of observing a beneficial stimulant response decreases as
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functional level decreases (Aman & Singh, 1991). Recent 
placebo-controlled studies suggest children with mild to 
moderate mental retardation and hyperactivity respond to 
stimulants in a manner similar to children with average 
intelligence and ADHD (Aman, Marks, Turbott, Wilsher, & 
Merry, 1991a). Stimulant medications are the most common 
behavior modifying drugs prescribed for individuals with 
mild developmental disabilities in special public school 
placements to address problems with inattention, 
distractibility, and excessive activity that interfere with 
learning (Crnic & Reid, 1989; Gadow & Kalachnik, 1981) . 
Stimulant medications are not generally recommended for 
students with severe or profound mental retardation (Aman & 
Singh, 1991; Chandler et al., 1988; Handen & Feldman,
1992).
Proponents of stimulant use with individuals with 
severe or profound mental retardation cite the 
methodological inadequacies of the early stimulant research 
with this clinical population (Aman & Singh, 1991) . The 
majority of the drug studies with the developmentally 
delayed population omitted (a) basic methodological 
features necessary for making conclusions about drug 
efficacy (e.g., random assignment of subjects to groups, 
placebo control or crossover design, double-blind 
observations, and standardized or reliable measurements),
(b) functional analyses of behavior disorders and/or failed 
to control environmental variables, (c) important
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participant features (e.g., age, gender, other 
medications), (d) standardized dose increments, and 
(e) objective behavior measures (Schaal and Hackenberg,
1994). The initial stimulant studies used adult, 
institutionalized persons with mental retardation who 
exhibited behaviors not typically addressed by stimulant 
medications (Aman & Singh, 1991; Aman et al., 1993b).
Group Efficacy Studies 
Recently, a number of sophisticated, large-group 
efficacy studies targeted MPH in children with mental 
retardation and ADHD or compared CNS stimulants with other 
medications (e.g., fenfluramine, thioridazine) and 
documented positive stimulant responses at efficacy rates 
approaching those observed in the average-IQ, ADHD 
population (Aman & Singh, 1986; 1991; Handen, Breaux, 
Gosling, Ploff, & Feldman, 1990; Handen et al., 1991; 
Handen et al., 1992). M.G. Aman and colleagues at the 
Nisonger Center for Mental Retardation and Developmental 
Disabilities at Ohio State University and B.L. Handen and 
colleagues in the Department of Pediatrics at the 
University of Pittsburgh School of Medicine have initiated 
independent efficacy series with MPH and other medications 
(thioridazine, fenfluramine) among intellectually 
subaverage and developmentally delayed children with ADHD. 
Nisonger Center Studies
The Nisonger Center research has targeted (a) the 
clinical effects of MPH, fenfluramine, and thioridazine on
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intellectually subaverage children (Aman et al., 1991a),
(b) the cognitive-motor performance of low-IQ children with 
ADHD receiving MPH and thioridazine (Aman, Marks, Turbott, 
Wilsher, & Merry, 1991b), (c) the laboratory effects of 
fenfluramine and MPH (Aman et al., 1993a) and (d) clinical 
and side effects of fenfluramine and MPH (Aman et al., 
1993b; Aman et al., 1997). Overall, Aman and colleagues 
found differential effects with MPH in relation to MA, IQ, 
and sustained attention. Specifically, MA and IQ may be 
important determinants of drug response; higher functioning 
individuals with ADHD show a more favorable response to 
MPH, and children with lower IQs show an adverse or 
indifferent response on both teacher and parent rating 
scales (Aman et al., 1991a; 1991b).
The Pittsburgh School of Medicine Studies
The University of Pittsburgh School of Medicine 
research team studied stimulant medication use with 
children dually diagnosed with mental retardation and ADHD. 
Studies targeted MPH (a) efficacy (Handen et al., 1990; 
Handen et al., 1992), (b) response predictor variables
(Handen, Janosky, McAuliffe, Breaux, and Feldman, 1994; 
Handen, McAuliffe, Janosky, Feldman, & Breaux, 1995),
(c) adverse side effects (Handen et al., 1991), and
(d) efficacy with behavioral interventions on classroom 
behavior (Johnson et al., 1994). Results indicated that 
overall drug response rates ranged from 64% to 7 5% but that 
a greater number of adverse side effects (e.g., motor tics,
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social withdrawal) were reported in comparison to studies 
of children with average intelligence.
Both the Nisonger and Pittsburgh research groups found 
effects of MPH with this population that are consistent 
with research conducted with children with ADHD but not 
diagnosed with mental retardation (Aman et al., 1991a; 
1991b; 1993a, 1993b, 1997; Handen, et al., 1990; 1991;
1992; 1994; 1995). Specifically, children with mental 
retardation in the high moderate to mild range and ADHD 
appear to respond to MPH at similar rates and in similar 
domains to that of the nonretarded population. The MPH 
side-effect studies indicated that children with mental 
retardation and ADHD may be at a greater risk for 
developing these side effects than the nonretarded 
population (Handen, et al., 1991). In a recent review of 
the literature, Aman (1996) concluded (a) children dually 
diagnosed with mental retardation and ADHD do respond to 
stimulant medication, (b) stimulant response rate is lower 
in children with mental retardation as compared to children 
with ADHD and average IQs, and (c) response rate may be 
positively related to functioning level (e.g., IQ, MA).
Within-Subject Simulant Efficacy Studies
Most studies evaluating the interactive effects 
between medication and specific environmental variables 
have used between-group designs that did not control for 
environmental contingencies. Poling and Cleary (1986) 
recommended applying behavior analysis research strategies
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to clinical psychopharmacology by (a) increasing the use of 
within-subject or single-subject designs (e.g., withdrawal, 
multiple baseline), and (b) using drugs as independent 
variables to determine how drugs affect carefully defined 
and measured target behaviors. The few research attempts at 
a multimethod approach to stimulant medication evaluations 
have the following limitations: (a) overreliance on 
subjective measures (self-report and rating scales);
(b) limited definitions of the primary problem behaviors 
(e.g., academic performance, compliance, inattention); and,
(c) limited clinical observations.
During the 197 0s and 1980s, five methodologically 
sound, single-subject studies compared MPH to behavioral 
treatments and demonstrated beneficial effects for MPH with 
contingency management facilitating appropriate behavior. 
(Ayllon, Layman, & Kandel, 197 5; Pelham, Schnedler,
Bologna, & Contreras, 1980; Shafto & Sulzbacher, 1977; 
Wulbert & Dries, 1977; Schell et al., 1986). Pelham et al., 
(1980) found combined drug and behavioral treatment to be 
more effective than either component alone. These studies 
demonstrated the utility of applied behavior analysis 
research in comparing medications to alternative treatments 
and in assessing behavioral side effects of pharmacological 
interventions.
During the past 10 years, the number of applied 
studies demonstrating the utility of single-subject designs 
in evaluating the relative and combined clinical
42
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
effectiveness of medication and behavioral interventions 
have increased (e.g., Blum et al., 1996; Johnson et al., 
1994; Shell et al., 1986; Stoner et al., 1994). Schell et 
al. (19 86) investigated the separate and combined effects 
of a behavioral intervention and one dose (0.3 mg/kg) of 
MPH on a child with mild mental retardation and found 
additive effects of the two interventions on correct 
responding to task. Johnson et al. (1994) used an 
alternating treatment, double-blind, placebo-controlled 
design with three children with ADHD and mental retardation 
and reported differential effects with interventions across 
MPH and placebo similar to those reported in single-subject 
studies within the average-IQ ADHD population (Northup, 
Jones et al., 1997 ; Northup et al., 1999; in press) . Blum 
et al. (1996) used a single-subject experimental
methodology to investigate the separate and combined 
effects of behavioral and pharmacologic intervention 
concurrently. Behavioral treatments based on functional 
analysis have been included in a few stimulant medication 
studies (Cooper et al., 1993; Fisher et al., 1989; Kayser, 
et al., 1997; Northup et al., 1999; in press).
Environmental Variables in Stimulant Efficacy Studies 
Programmed consequences and MPH have demonstrated 
efficacy in reducing the disruptive behavior of children 
with ADHD. A growing body of research is evaluating the 
interactive effects between MPH and environmental variables 
(e.g., the behavioral mechanism of the drug action of MPH
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in applied settings). Whalen, Henker, Collins, Finck, and 
Dotemoto (1979) used a between-group design to demonstrate 
a possible interactive effect between MPH and classroom 
antecedent conditions varying by noise level and task 
pacing. Wilkison, Kircher, McMahon, and Sloane (1995) used 
a between-group design to demonstrate boys with a diagnosis 
of ADHD earned significantly more of a generalized 
reinforcer (pennies) when they received MPH as compared to 
placebo.
Northup and colleagues have developed a single-subject 
methodology for concurrently assessing (a) the effects of 
common classroom contingencies (e.g., peer attention) and 
MPH within a muiltielement design (Northup, Jones et al., 
1997), (b) the differential effects for reinforcer
assessments with children receiving MPH and placebo 
(Northup, Fusilier, Swanson, Roane, & Borrero, 1997), and
(c) the separate and interactive effects between common 
classroom contingencies (e.g., timeout, teacher reprimand) 
and MPH on disruptive and off-task behaviors (Northup et 
al., 1999; in press).
Blum et al. (1996) conducted a controlled comparison 
of baseline conditions, a behavioral intervention alone,
MPH alone, and a combination of MPH and a behavioral 
intervention for the treatment of disruptive behavior in 
three children with severe to profound mental retardation. 
The primary dependent variable was the percentage of time 
engaged in disruptive behavior during a 10-minute task
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session (i.e., placing blocks or books into a specific 
container). Engagement with task, defined as the child 
picking up or walking with a toy or book in the direction 
of the container was also measured. The behavioral 
intervention involved differential reinforcement (DRA) and 
guided compliance to decrease the disruptive behavior and 
increase task engagement. A forced-choice preference 
assessment (Fisher et al., 1992) was used to identify the 
reinforcers used in the differential reinforcement of 
alternative behavior (DRA) procedure. Two of the children 
demonstrated decreases in disruptive behavior with 
concurrent increases in task engagement in response to MPH. 
Three children demonstrated similar improvement in response 
to the behavioral intervention. The relative efficacy of 
the two interventions varied for the two children 
responding to MPH and behavioral treatments. Blum et al. 
(1996) demonstrated the idiosyncratic character of response 
to MPH and behavioral treatment in children with severe to 
profound mental retardation and recommended both behavioral 
and pharmacologic interventions be considered when treating 
disruptive behaviors in this population.
Summary
Methodology in the field of psychopharmacology with 
the developmentally delayed population has been 
historically poor (Aman & Singh, 1988). Dosage adjustments 
have been a problem with both individualized and 
standardized regiments commonly used (Aman & Singh, 19 88) .
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The dominant measure of drug response has traditionally 
been clinical global impressions; however, recent studies 
have relied on direct observations, standardized rating 
scales, and tests of learning (Thompson et al., 1993; 
Baumeister & Sevin, 199 0).
The basic assumption in behavior analysis is that most 
disruptive behaviors are operants sensitive to reinforcing 
contingencies. Behavior pharmacology uses single-subject 
designs in medication efficacy studies to determine the 
effects of pharmacological variables (e.g., dose) on 
behavioral mechanisms of action (Schaal, & Hackenberg,
1994; Baumeister & Sevin, 1990). Behavioral pharmacologists 
attempt to determine what are the drug effects on 
environmental variables that normally regulate the behavior 
of interest. For example, analysts attempt to determine 
what environmental contingencies the behavior is naturally 
responsive to and determine if any post-medication behavior 
change is the result of dose response. Behavior 
pharmacology recommend medication studies include a 
multidimensional analysis to establish the temporal pattern 
and repetitiveness of the target behavior, determine 
behavioral or cognitive deficits that might be maintaining 
the behavior, and specify the degree the behavior is under 
environmental control (Thompson, 1993).
Behavioral pharmacology assesses drug effects on 
problem behavior; functional analysis of serious behavior 
problems has demonstrated utility with behavior disorders.
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Surprisingly, behavioral treatments based on functional 
analysis have been included in only a few medication 
studies (Cooper et al., 1993; Fisher et al., 1989; Kayser, 
et al., 1997; Northup et al., 1999; in press).
The idiosyncratic effect of MPH across behavioral 
classes directly impacts which behaviors and measures will 
be included in ADHD-stimulant medication studies. Pelham et 
al. (1991) recommends direct observations, standardized 
dose increments, academic performance measures, behavioral 
ratings across raters, direct measures of behavioral change 
to determine dosage effects, measures of social validity, 
and convergent validity of observational measures with data 
from other sources. Although single-subject methodology can 
easily be adapted to meet these goals, most medication 
studies have used between-group designs and used direct 
observations as supplementary rather than primary measures 
(Gulley & Northup, 1997).
Many group studies with children with ADHD and average 
IQs have combined medication and behavioral treatments. The 
general consensus of these studies is that behavioral 
treatments in combination with low doses of MPH are more 
effective than either intervention alone for children with 
ADHD and average intelligence (Carlson, Pelham, Milich, & 
Dixon, 1992; Pelham Milich, & Walker, 1986). The degree to 
which these group studies are able to reflect the response 
of individual children to these interventions is not known. 
Blum et al. (1996) used a single-subject experimental
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methodology to investigate the separate and combined 
effects of behavioral and pharmacologic intervention 
concurrently and found no evidence of an additive or 
synergistic effect of the two interventions; no studies 
have used have used functional analysis to determine 
effective behavioral and medication treatments or 
investigate the separate and combined effects of these 
treatments.
MPH has established efficacy in average IQ and mild 
disability populations for the treatment of disruptive 
behaviors in educational and training settings. It would 
appear to be an appropriate choice in a medication efficacy 
study comparing medication status and function-related 
intervention with clinically significant disruptive 
behaviors.
Treatment prevalence studies have shown psychotropic 
and anti-epileptic drugs are prescribed frequently in the 
mental retardation population (Aman & Singh, 1988; Aman, 
Sarphare, & Burrow, 1995). Traditionally, lower IQ, adult, 
and institutionally placed individuals with disruptive 
behaviors have been treated with medications that have 
dangerous side effects (e.g., neuroleptics,
antiepileptics). Stimulant medication has been infrequently 
used among individuals with mental retardation, especially 
in residential facilities (Aman & Singh, 1991). In contrast 
to other drugs commonly used to control disruptive 
behaviors in the mental retardation population, MPH has
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virtually no long-term side-effects. Stimulant medications 
have been considered too short-acting (e.g., half-life of 2 
to 3 hours) to meet the long-term and 24-hour needs of 
these individuals. Recent research showing positive effects 
has rekindled interest in stimulant medications to control 
disruptive and destructive behaviors in individuals with 
severe to profound mental retardation.
Purpose
The purpose of this study was to demonstrate the 
utility of a single-subject design and functional analysis 
in determining the separate and combined effects of 
short-action stimulant medication and behavioral treatments 
with disruptive behaviors of persons with severe to 
profound mental retardation. This study developed an 
individualized, comprehensive assessment of medication 
effects that includes multiple behavior measures in a 
variety of settings to determine (a) an optimal dose, if 
any, of stimulant medication, (b) differential medication 
effects at various doses and across various target 
behaviors, (c) changes in academic or training performance 
and care provider ratings in relation to child behavior, 
and (d) separate and combined effects of stimulant 
medication and behavioral treatments on the disruptive 
behavior and task engagement of children with severe to 
profound mental retardation.
This study extended single-subject stimulant 
medication efficacy research within the ADHD population by
49
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(a) targeting children in the severe to profound range of 
mental retardation, (b) evaluating individual MPH effects 
on academic or training tasks unique to this population,
(c) including a functional analysis assessment component, 
and (d) analyzing the individual separate and combined 
effects of mediation and behavioral treatments on 
disruptive behaviors and task engagement.
This study extended previous MPH-efficacy studies 
within the mental retardation population by (a) using 
multiple assessments of different behaviors conducted in a 
variety of settings in a single-subject design,
(b) exploring the utility of analog functional analysis in 
drug and behavioral treatments for disruptive behaviors and 
task engagement of children diagnosed with severe to 
profound mental retardation, and (c) evaluating 
drug-behavior interactions (i.e., possible behavioral 
mechanism of drug actions).
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METHOD
Participants
Five children, ages 10 to 15, with severe to profound 
mental retardation participated in this study. All children 
engaged in severe disruptive behavior and resided in a 
private, Intermediate Care Facility for Mental Retardation 
(ICF-MR). Inclusion criteria required that each child
(a) have a current Diagnostic and Statistical Manual of 
Mental Disorders-IV (DSM-IV) diagnosis of Mental 
Retardation (severe to profound range), (b) display 
referral behaviors considered to be harmful to self or 
others or to significantly interfere with training or 
educational development, (c) be between ages of 6 and 18,
(d) have a physician recommendation for a trial of 
methylphenidate (MPH), and (e) have signed authorizations 
from the facility, prescribing physician, and parents or 
legal guardians consenting to the participation in a 
medication evaluation to identify the therapeutic dose, if 
any, of MPH for optimal functional training and social 
behavior. Demographic information for the children is 
provided in Table 2.
Cade was a 12-year-old, white male who had resided at 
the facility for six years. He called out words and phrases 
(go on the bus, missing toys, find the toys) disruptively 
in the classroom. He followed simple commands (sit down, 
stand up, bring) and knew his daily routine.
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Cooper was a 10-year-old black male, who had resided 
at the facility for six months. He could recite the 
Table 2. Participant Demographic Information
Name Age
Cade 12
Cooper 10
Frankie 12
Joel 15
Mark 13
Diagnosis Medication Behaviors
MR-Profound 
Self-injurious 
behavior (SIB)
MR-Severe 
Hyperactivity
MR-Profound 
Overactivity
MR-Severe 
Hyperactivity
MR-Severe 
Hyperactivity
None Hyperactivity
Out of seat 
Calls out 
Twirls in circles 
Hand/finger play 
Head bangs wall 
Wrist/elbow hits
None Hyperactivity
Runs away 
Pinches 
Screams
Plays with toilet
None Hyperactivity
Throws objects 
Out of seat 
Grabs glasses 
Destroys property 
Noncompliance 
(flops to ground; 
verbal refusal) 
Disrobes
None Body rocks
Runs away 
Calls out 
Tantrums (cries, 
rolls on floor) 
Hits knees, hands 
on floor 
Throws objects
None Hyperactivity
Distractable 
Excessive talking 
Hits, kicks,trips 
Runs away
___________ Destroys property
alphabet and say his name and some words, but he rarely 
spoke. He vocalized loud noises in the classroom and 
laughed when corrected. He could copy the numbers 1-10 and 
the alphabet, count to 20, and identify shapes. His
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academic performance was generally contingent on one-to-one 
staff attention. He would throw paper in the air, overturn 
his desk, or make disruptive noises if the aide left his 
side.
Frankie was a 12-year-old, white female who had 
resided at the facility for six years. She was marginally 
verbal, and communication was restricted to inconsistent 
gestures (point, wave, smile, head shake), vocals, some 
words (ball, eat, mama), and signs (toilet, eat). Although 
capable of performing many self-help tasks, Frankie usually 
waited on others to dress and toilet her. She required 
one-to-one supervision and engaged in disruptive behaviors 
harmful to herself or others if ignored (e.g., pulling on 
electrical cords, appliances, throwing herself on the 
ground), property destruction (pulling papers from walls, 
throwing objects), or aggression (throwing objects at 
people, pinching, pulling or pushing). For example, prior 
to be being included in this study, Frankie had broken her 
arm by throwing herself on the side of a concrete side 
walk.
Joel was a 15-year-old, white male who had resided at 
the facility for nine years. He was marginally verbal 
(mommy, bye, dada, wawa, coke, baba, eat). He communicated 
his needs by pointing, vocalizations, and some functional 
signs. He responded to his name, identified common 
environmental objects by pointing, and followed most simple 
commands. He exhibited stereotypies (body rocking, twirling
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objects in his hands). A preferred item was a clear plastic 
bottle, and he would throw himself on his knees and slam 
his hands on the floor when his teacher or support workers 
removed the bottle to engage him in a training activity.
Mark was a 13-year-old, black male who had lived at 
the facility for 4 years. Mark was verbal, spoke in short 
sentences, and repeatedly sought adult attention. For 
example, he would inappropriately recruit attention by 
calling out in class (Is this right?. Come see?. Hev. did I 
do good?). Ignoring him usually resulted in his leaving his 
seat and engaging in disruptive, attention-seeking 
behaviors (arm pats and tugs, repetitive verbal requests, 
opening the teacher's desk, tripping a peer, and destroying 
property).
Signed informed consent forms were obtained from the 
parents or legal guardians (Appendix A). In addition, 
approval for this study was obtained from the facility's 
Human Rights Committee. A written description of the 
assessment was provided to the prescribing physician and a 
signed agreement to participate was obtained.
Settings and Materials 
The preference assessments and analog analyses were 
conducted at the residential facility in a training room 
equipped with a one-way observational window and intercom 
with no peers present. Medication and intervention 
observations were conducted in self-contained classroom 
settings unless the teacher indicated the session might be
54
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
disruptive to some on-going activity. Each self-contained 
classroom housed 6 to 8 students, the teacher, and two 
aides. Due to the normal flow of school activities, the 
number of students and professional staff in the classroom 
varied during the observation.
In analog assessments, the child was seated with an 
individualized task or preferred toys at a table. When 
assessed in the classroom, the child was seated either at a 
desk or a table located to the side or back of the 
classroom. For one child (Frankie), who threw blocks during 
the assessment procedure, some classroom observations were 
conducted with a partition (5 by 8 feet) separating her and 
the other children.
Response Definition and Measurement 
Independent Variables
Medication Status
The primary independent variable was medication status 
at placebo, low (0.3 mg/kg), moderate (0.6 mg/kg), and high 
(0.9 mg/kg) dose of MPH. The physician initially prescribed 
a placebo and a low dosage of MPH and titrated upward if 
indicated. Cade received placebo and two dose levels of MPH 
(5, 10 mg). Cooper, Joel, and Mark received placebo and two 
dose levels of MPH (10, 15 mg). Frankie received placebo 
and three dose levels of MPH (5, 10, and 15 mg).
Behavioral Interventions
Secondary independent variables were the behavioral 
treatments that were developed for each child based on the
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prior functional analysis. Behavioral treatments were 
evaluated both alone and in combination with MPH to 
determine the effectiveness of a behavior intervention as 
an alternative to MPH and the maximal effectiveness of the 
combined treatments. The behavioral treatment involved 
differential reinforcement of appropriate behavior 
following a verbal prompt or model with graduated 
compliance to complete the task. The child earned a
reinforcer if he or she performed the task following the
verbal request or model. A time out procedure was used with 
three of the children if a disruptive behavior occurred 
during the task.
Dependent Variable and Response Definitions 
The primary dependent variable was the percentage of 
10-second intervals the child engaged in disruptive 
behavior. Specific targeted disruptive behaviors were 
determined by individual referral concerns and
pre-assessment classroom observations, and included the
following: (a) inappropriate vocalizations (any vocal sound 
or verbalization disruptive to the situation, not preceded 
by the child raising his or her hand), (b) playing with 
objects (touching any object that was not part of the 
assigned educational or training task), (c) out-of-seat 
behavior (full body weight not supported by chair or the 
child's buttocks being removed from the chair for longer 
than 3 seconds), (d) aggressive behavior (e.g., hitting, 
slapping, biting, kicking, pinching, scratching, pushing
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others and throwing/pushing objects), (e) repetitive, 
nonfunctional behaviors injurious to self (e.g., hitting, 
slapping, biting, pinching, scratching self) or disruptive 
to training or educational task (e.g., hand or finger 
gazing/playing, body/head rocking), and (f) resistive or 
refusal behaviors (e.g., pushing material away, verbal or 
gestural refusal, turning body or head from task).
Other dependent measures were task engagement, and 
scores from the behavior rating and side-effect scales.
Task engagement was defined as the percentage of intervals 
in which the child touched, picked up, or walked with a 
task material in the direction of the work site (e.g., held 
a pencil, turned his paper over). Engagement was coded from 
the onset of the behavior until disengaged for 5 seconds. 
Engagement was not coded if the child exhibited disruptive 
behaviors or was placed in time out.
Data Collection and Reliability 
Data collected included (a) the percentage of 
intervals in which disruptive behaviors occurred,
(b) percentage of intervals in which the child was task 
engaged, (c) productivity or the amount of academic work 
completed, (d) accuracy or the percentage of work completed 
correctly, and (e) the integrity of the assessment 
condition or intervention (percentage of target responses 
followed by correct therapist response).
All child responses were manually recorded using a 
10-second partial interval recording procedure with a tape
57
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
recorder signaling each interval during 10-minute sessions. 
A second observer independently recorded data 
simultaneously with a primary observer to establish 
interobserver agreement. Observers were required to 
complete the following training procedures: (a) average at 
least 90% agreement with previously trained observers 
during two videotaped sessions, and (b) train in vivo with 
an experienced graduate student until the trainee averaged 
at least 9 0% agreement with previously trained observers.
In all cases, interobserver agreement was calculated 
on an interval-by-interval basis for each response 
definition by (a) dividing the session into consecutive 
10-second intervals, (b) dividing the number of agreements 
(occurred/did not occur during the interval) by the sum of 
agreements and disagreements and multiplying by 100%, and
(c) averaging that number across sessions (Kazdin, 1982).
Interobserver agreement was assessed during 30% of all 
sessions (range 20% to 67%) for each child. Interobserver 
agreement was obtained on an average of 32% (range, 25% to 
50%) for Cade, 35% (range, 20% to 50%) for Cooper, 29% 
(range, 25% to 33%) for Frankie, 30% (range, 20% to 67%) 
for Joel, and 35% (range, 25% to 67%) for Mark.
Interobserver agreement exceeded 9 0% for all dependent 
variables. Table 3 presents interobserver agreement for 
each child across all conditions.
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Table 3. Percentage of Interobserver Agreement across 
Conditions
Cade Cooper Frankie Joel Mark
Phase 1 Condition
Attention 100 91 96 96 99
Alone 98 99 96 96 98
Control 98 99 100 100 99
Demand 98 94 100 99 96
Tangible N/A 97 N/A 99 99
Total (Phase 1) 98 95 98 98 98
Phase 2 Conditions
Attention 98 99 97 98 99
No Interaction 99 99 98 97 98
Total (Phase 2) 98 99 98 97 99
Phase 3 Conditions
MPH 98 100 98 N/A N/A
MPH plus BI 99 99 98 N/A N/A
BI 98 95 97 100 98
BI plus Placebo 97 99 96 N/A N/A
Total (Phase 3) 98 98 97 100 98
Procedural Integrity
Child and therapist behaviors were observed to assess 
the degree to which intervention sessions were conducted as 
intended. The therapist (experimenter) behaviors of toy 
presentation, demands, time out, tangible deliverance, and 
attention were recorded during relevant conditions to 
ensure the procedural integrity of all sessions. Demands 
were defined as the first verbal instruction provided 
during a three-prompt instructional sequence from the 
therapist directed toward the child. Compliance was scored 
when the child completed the instruction after the initial 
vocal or modeled prompt. Time out was defined as removal of 
work materials and therapist attention during a 10-second 
interval. Tangible delivery was defined as the therapist 
providing the child access to preferred toys during a 
10-second interval. Attention was defined as the therapist
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providing the child with a brief vocal reprimand, praise, 
and/or physical contact during a 10-second interval.
Procedural integrity was calculated by two methods in 
all sessions for each child. First, integrity was 
calculated as a percentage of target behaviors that were 
followed by the therapist responses specified for each 
assessment condition or intervention, and the nonoccurrence 
of any other dependent variable during the same or 
subsequent 10-second interval. Second, a percentage of 
intervals was calculated for the occurrence of intervention 
independent variables that were not contingent upon a 
target behavior, in order to indicate experimental control. 
Procedural integrity during analog and classroom functional 
analysis sessions averaged 96% for all conditions (range 
90% to 100%) and 96% for all children during the treatment 
analyses (range 90% to 99%) .
Rating Scales
Teachers and direct support workers (DSWs)completed 
daily behavior rating scales when the child received 
medication or placebo. The scales were based on the School 
Situation Questionnaire-Revised, the Home Situation 
Questionnaire-Revised, the Child Attention Profile, and the 
Side Effects Rating Scale (Barkley, 1990). The Intervention 
Rating Profile-15 (Martens, Witt, Elliott, & Darveaux,
1985) was administered prior to treatment and at the end of 
the study. The authors of these scales have given 
permission to duplicate or alter these scales for clinical
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or research purposes. The Child Attention Profile and the 
Side Effects Rating Scale were retyped on separate pages 
and retitled, Behavior Rating Scale. Written instructions 
directed the rater to mark the items as they applied to the 
child's behavior that day. Two versions of the Intervention 
Rating Profile-15 were used to obtain pre- and 
post - treatment ratings from teachers and direct support 
workers. A description of the scales follows.
The Child Attention Profile (CAP)
The CAP is a 12-item scale developed to measure 
inattention and overactivity (Barkley, 1991) and is 
frequently used in stimulant drug efficacy studies 
(Barkley, 1990). The child's behavior is rated on a 3-point 
Likert scale ranging from 0 (not true) to 2 (very or often 
true). Five items loading on the overactivity scale and the 
seven loading on the inattention scale were chosen to 
create a brief instrument to assess stimulant drug effects. 
Higher CAP scores (84 to 108) correspond with severe levels 
of inattention and disruption. Mid-range scores (37 to 83) 
indicate moderate problems and lower scores (0 to 36) 
indicate mild to no problems with inattention and 
disruption.
The Home Situations Questionnaire-R (HSO-R)
The HSQ-R is a 14-item scale that assesses specific 
problems with attention and concentration across a variety 
of home and public situations (Barkley, 1991). The primary 
support worker first endorses all items as Yes or No and
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then rates Yes items for severity on a 9 -point Likert scale 
from 1 (mild) to 9 (severe). The scale yields scores for 
the number of problem settings (e.g., alone, with children, 
at meals) and an overall problem severity score. Higher 
HSQ-R scores (98 to 126) correspond with severe levels of 
inattention and poor concentration in home situations. 
Mid-range scores (48 to 97) are associated with moderate 
levels of inattention, and lower scores (0 to 47) indicate 
mild to no problems in these areas.
The School Situations Questionnaire-Revised (SSQ-R)
The SSQ-R is an 8-item scale assesses specific 
problems with attention and concentration across a variety 
of school settings (Barkley, 1991). The teacher or aide is 
asked to indicate whether the child displays behavior 
problems in each of 8 common educational settings. The 
rater first endorses the items as Yes or No and then rates 
Yes responses for severity on a 9 -point Likert scale from l 
(mild) to 9 (severe). The scale yields a score for the 
total number of problem settings and an overall problem 
severity score. Higher SSQ-R scores (56 to 72) correspond 
with severe levels of inattention and poor concentration in 
home situations. Mid-range scores (32 to 55) are associated 
with moderate levels of inattention and lower scores (0 to 
31) indicate mild to no problems in these areas in the 
home.
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Side Effects Rating Scale
The Stimulant Drug Side Effects Rating Scale (SDSERS; 
Barkley, 1990) is a 17-item, 9 -point Likert scale ranging 
from 0 (absent) to 9 (serious) that is used to report 
whether the individual is experiencing common side effects 
(e.g., headaches, stomachaches, insomnia) associated with 
the use of stimulant medication. The scale was retyped and 
titled, Behavior Scale. Four additional items were included 
(i.e., mood changes quickly, hostile/angry, 
nervous/anxious, and agitated) to assess side-effects in 
individuals with profound and severe developmental delays. 
Higher SDSERS scores (147 to 189) correspond with severe 
levels of observed MPH side effects. Mid-range scores (64 
to 146 are associated with moderate levels of MPH side 
effects and lower scores (21 to 63) indicate mild levels to 
no observed problems. Side-effect scales were reviewed 
daily for individual items and a total side effects score 
was obtained by averaging daily ratings across all items 
for each child.
The Intervention Rating Profile-15
The Intervention Rating Profile-15 (Martens et al.,
19 85) is a 15-item survey with items scored on a 6 -point 
Likert scale ranging from strongly disagree to strongly 
agree. Scores range from 15 to 90 with higher scores 
representing greater acceptability. The purpose of the 
questionnaire is to obtain information about the care 
provider's reaction to a proposed or completed intervention
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(Witt and Martens, 1983). In this study, Two questionnaire 
versions were used to determine factors that may be related 
to the use of the medication or behavior interventions. The 
Behavior Intervention Rating Form evaluated the teacher and 
support worker's assessment of the acceptability of the 
behavior interventions used in this study prior to and 
following implementation. The Medication Intervention 
Rating Form assessed the teacher and support worker's 
opinions regarding the acceptability of a medication 
intervention prior to and following the medication 
evaluation.
Design
All functional analysis conditions were conducted in a 
single-subject multielement or alternating treatment 
design. All medication evaluations were conducted in an 
alternating treatments design in which each dosage of MPH 
randomly alternated with a placebo. After an optimal dosage 
of MPH was determined for three of the children, behavioral 
interventions were randomly alternated with MPH, a placebo, 
or no pill.
Procedures
Phase 1: Preference Assessment and Functional Analysis 
Preference Assessment
Potential reinforcers for the functional analysis were 
identified for each child in free operant preference 
assessments based on procedures developed by Roane,
Vollmer, Ringdahl, and Marcus (1999). The preference
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assessments were used to identify potential reinforcers 
that could be used during the functional analysis and/or 
incorporated into behavior interventions (phase 3). For 
each child, 10 stimuli were included in the assessment. 
Preference assessment stimuli were selected based upon 
teacher or support worker report, the child's endorsement 
(if verbal), and preassessment observations. Assessments 
were conducted in an empty observation room with 
observations made through a one-way window. Prior to each 
assessment, stimuli were presented individually for 45 
seconds. Then, the 10, equally spaced, stimuli were 
presented concurrently on the floor. The children were free 
to ignore all items or interact with any of the items 
individually or collectively during the session. No items 
were removed during the assessment. Each child was exposed 
to a minimum of two 5-minute sessions. All contact between 
the child's hands or fingers with a stimulus item were 
scored using a 10-second partial interval recording method.
Each 5 -minute session was divided into 30, 10-second 
intervals. The percentage of partial 10-second intervals in 
which the child manipulated each stimulus was divided by 
the total number of intervals and multiplied by 100 to 
yield a preference index per item. One to three stimuli 
with the largest index of preference were considered for 
use in the functional analysis.
Table 4 presents the preferred items identified during 
the free-operant assessments for each of the children. The
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primary preferred item was also used in the subsequent 
academic and behavioral interventions developed for Joel 
and Mark.
Table 4. Preference Assessment Indexes for Each Child
Child Items Preference Index
Frankie Person (social interaction) 67%*
Favorite song on cassette 37%
Toy Guitar 33%
Cade Person (social interaction) 3%
Cooper Waterfall tube 100%
Mark Toy guitar 82%
Social interaction 35%
Radio 33%
Joel Plastic bottle 52%
Person (social interaction) 20%
Pen and paper 18%
* Frankie sat in person's lap and manipulated toys.
Functional Analvsis
The functional analysis was based on procedures 
described by Iwata et al., (1994/1982), Sasso et al.(1992),
and Northup et al. (1999, in press). The analog analysis 
was conducted by the therapist in a room with a one-way 
observation window. The classroom functional analysis was 
conducted by the therapist in the class or training room. 
During the functional analyses, each child was exposed to 
four to six experimental conditions (escape, attention, 
tangible, alone, control, and no interaction). Five trained 
therapists conducted the sessions wearing shirts 
color-coded for each condition. When possible, the same 
therapist conducted all sessions across that condition for 
the child. Table 5 describes the training task and 
materials used in the attention, tangible, alone, and no 
interaction conditions for each child.
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Table 5 , Instructional Tasks and Materials
Child Task in Attention, Alone, 
No Interaction, Tangible
Materials Task in 
Demand
Materials
Frankie Shape discrimination 
and sorting
Playskool 8" x 8" cube 
18 insertable forms
Discrimination 4
5
shapes
containers
Cade Shape discrimination 
and sorting
Playskool 8" x 8" cube 
18 insertable forms
Discrimination 4
5
shapes
containers
Cooper 3 Copy worksheets Name model, 10 copy lines 
1-10 model, 10 copy lines 
A-L model, 10 copy lines
Discrimination 4
5
shapes
containers
Mark Color sheets Bunny on 8fct" x 11" paper 
Jumbo crayon
Discrimination 4
5
shapes
containers
Joel Three-piece 
bolt-set assembly
3 assembly trays 
15 3-inch bolts 
15 washers, nuts
Discrimination 4
5
shapes
containers
Demand condition. Instructional tasks were similar to 
those presented in the child's educational or training 
environment, but were identified as difficult (i.e., less 
than 7 0% accuracy in previous trials). A graduated, 
three-prompt sequence was used to present instructions 
(Horner & Keilitz, 1975). The therapist (a) verbally 
requested the child to perform a task, (b) modeled 
compliance with the instruction following five seconds of 
noncompliance with the verbal request, and (c) physically 
guided the child (hand over hand) to comply with the 
instruction after five seconds of noncompliance with the 
modeled request. Praise was delivered contingent on a 
correct response following the first or second request. The 
three-prompt, demand sequence trial was completed at 
pre-set intervals (15 to 30 seconds) dependent upon the 
identified performance rate of the child. Occurrence of a 
targeted disruptive behavior resulted in termination of the 
instruction trial for 30 seconds. Thus, the child escaped 
the demand sequence or task contingent through a target 
response (e.g., aggression). The purpose of this condition 
was to test for behavioral responsiveness to escape as a 
reinforcing consequence.
Attention condition. During this condition, the child 
was seated at a table with a training task that could be 
completed with 7 0% to 90% accuracy following an initial 
instruction and model (e.g., assembling bolt-washer-nut 
units). The therapist gave the initial instruction (e.g.,
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Sit cruietlv and put these together) , moved away from the 
child, and appeared to be busy and not attending to the 
child. The therapist only attended to the child to deliver 
statements of concern or reprimands following each target 
response. The purpose of this condition was to determine 
responsiveness of the target behavior to positive 
reinforcement in the form of attention.
Materials or tangibles condition. This condition was 
included for children who exhibit a targeted behavior when 
preferred stimuli were blocked or withdrawn. The preferred 
stimulus was exposed to the child for 2 minutes prior to 
the session. The stimulus was removed from reach but 
remained visible once the session began. The child was 
seated at a table with the same training task and initial 
instruction used in the attention condition. The therapist 
monitored the task while walking about the room. The 
therapist made the preferred stimulus available to the 
child for 30 seconds contingent upon a target response.
When the target behavior occurred, the therapist 
immediately moved the preferred stimuli to the side of the 
table within reach of the child for 30 seconds, and removed 
the stimuli to the initial position after allowing 30 
seconds of access. The purpose of this condition was to 
determine responsiveness of the target behavior to positive 
reinforcement in the form of tangible stimuli.
Alone condition. During this condition, the child was 
alone in a room with a one-way observational window. All
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neutral stimuli were removed. The child was seated at a 
table with the same training task described in the 
attention and materials conditions. The therapist left the 
room after placing the task on the table and delivering the 
instruction. No programmed consequences were provided for 
any targeted behavior, and no interaction occurred between 
the therapist and the child. The purpose of this condition 
was to determine if the target behavior would persist 
independent of social consequences in a relatively barren 
environment.
Plav (control) condition. During this condition, the 
child was seated at a table with a preferred task or toy 
(e.g., radio, musical instrument). The therapist sat at the 
table with the child and provided attention (praise, 
conversation, pats or rubs to arms or back) on a 
differential reinforcement of other behavior (DRO) schedule 
with a mean inter - reinforcement time (IRT) of 15 seconds 
and no programmed consequences for a target behavior. The 
schedule of reinforcement delivery varied for each child 
dependent upon his or her current disruptive behavior rate. 
This condition served as a control condition in that the 
child had access to attention and there were no 
instructional demands to complete the task during the 
session (Iwata et al., 1994/1982).
No interaction (ignore) condition. The child was once 
again seated at his desk in the classroom with the same 
training task used in the attention, tangible, alone, and
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play conditions. The therapist walked about the room 
ignored all appropriate and inappropriate behavior, and 
delivered no attention. This condition is similar to the 
alone condition but assesses the effects of the presence of 
a noninteracting adult or class peers on the disruptive 
behavior.
Phase 2: Medication Evaluation 
General Procedures
Following the initial functional analysis, 10-minute 
baseline probes were conducted in the classroom using the 
two functional analysis conditions in which the highest 
levels of target behavior were exhibited. The children were 
then observed in one-day (low dose) or two-day (medium or 
high dose) blocks while receiving placebo or MPH, once each 
morning and afternoon for 4 days (low dose) or 8 days 
(medium or high dose). All behavioral observations were 
conducted at the same time daily in the classroom while the 
child completed a task supervised by the therapist. 
Observations were made 1 to 2 hours after administration of 
either medication or placebo.
The purpose of the classroom analysis was to determine 
the effects of medication status on disruptive behaviors in 
academic or training settings under two controlled 
environmental conditions (e.g., no interaction or 
attention) for which analog functional analysis effects had 
been previously demonstrated.
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Phase 3: Behavioral Intervention
Phase 3 was designed to evaluate the effects of 
different treatments in reducing disruptive behavior and 
increasing task engagement in the following treatment 
conditions: behavioral intervention alone, behavior 
intervention plus placebo, MPH alone, and MPH plus behavior 
intervention. This phase compared the effects of MPH and a 
function-related behavioral intervention alone and together 
in effectively reducing disruptive behavior and increasing 
task engagement for the children identified as MPH 
responders. For the children who were non-responsive to 
MPH, this condition evaluated whether a function-related 
intervention would effectively reduce the target behavior 
while concurrently increasing task engagement.
Intervention Development
In general, the behavioral intervention was based on 
removing or interrupting the environmental contingency 
associated with the highest levels of inappropriate 
behavior and, whenever possible, providing the same 
reinforcement for appropriate behavior; however, as the 
functional analysis indicated high levels of disruptive 
behavior during the alone condition for all children, a 
variety of antecedent manipulations were also included in 
the behavior intervention. For some of the children, 
assessment observations indicated the task or task 
presentation could be altered to better meet the child's 
current functional level or increase overall task
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performance. Whenever a functional analysis condition was 
associated with increased task engagement or reduced levels 
of disruptive behavior, essential components of that 
condition were included in the intervention. For example, 
disruptive behavior decreased and task completion increased 
during the demand condition for all participants. Thus, a 
DRA with graduated compliance procedure was modeled on the 
three-prompt, demand sequence (prompt, model, graduated 
compliance). For Mark and Joel, the items used during the 
materials or tangible condition were incorporated with the 
DRA for functional communication training.
Cade. Cade's task was to correctly place a square, 
triangle, and circle from left to right in a large form 
board with generalization to similar tasks (i.e., a 
smaller, similar form board, Formfitter cube used in the 
initial analysis). An analysis of the shape sorting task 
was conducted and differential reinforcement with graduated 
compliance in a three-prompt sequence (verbal prompt, 
model, graduated compliance) was selected to train the 
concept of putting in the multiple shapes. Stereotypies 
that were neither task disruptive nor precursors to more 
serious SIB were ignored. Verbal interruption (No) with a 
5-second basket hold was the intervention for head banging, 
striking wrist or elbow with objects and pre-SIB 
stereotypies (elevated arm and hand posturing that preceded 
elbow and wrist strikes). The procedure also had an escape 
extinction component that prevented escape from the task.
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The basket hold was followed by re-presenting the task 
using the hands down and get ready intervention in his 
current IEP. The therapist would release Cade from the 
hold, and say, "Hands down, get ready", guide Cade's hands 
to midline on the table, and restart the task. The brief 
time out was used only with behaviors that had been 
observed to precede to self-injurious behaviors (head or 
elbow hitting). It was gradually faded to a verbal prompt 
(hands down, get ready).
Cooper. Cooper's academic task involved verbally 
identifying letters presented in a Curriculum Based 
Measurement (CBM) format. Previous observations indicated 
Cooper would disrupt the learning task by leaving his seat 
and disruptive behavior would increase when verbally 
corrected. Pats to the back or arms and extended verbal 
praise directed to Cooper resulted in loud disruptive 
laughing, call outs, or aggressive behavior toward the 
teacher. Thus, the academic setting was rearranged to limit 
physical contact, and the need to verbally reprimand out of 
seat behavior. The therapist was seated to the left and 
slightly behind Cooper at a table, and Cooper's right side 
was immediately next to the wall. Cooper could escape the 
task only by sliding under the table.
Differential reinforcement with graduated compliance 
in a three-prompt sequence was selected to train the task.
A 30-second time out was the intervention for disruptive 
behavior. The therapist would point at a letter with a
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pencil, and say "This is If there was no response in
3 seconds, he would put Cooper's finger on the letter and 
say "This is If there was no response in 3 seconds,
he would put Cooper's finger on the letter and say "This is
a ___". Compliance on step one or two earned a one-word,
praise statement (Good). The therapist removed the task and 
turned away for 30 seconds when a disruptive behavior 
occurred (time out). At the end of the time out period, 
Cooper was returned to his chair and the first prompt was 
presented again.
Frankie. Frankie's academic task was identical to 
Cade's except for the forms used in the large form board. 
Frankie's forms were made of cardboard and packing tape for 
noise reduction and to reduce the possibility of injury to 
others when the forms were thrown. Frankie's behavioral 
intervention used alternate seating, differential 
reinforcement with graduated compliance, and a 30-second 
time out with an in-seat requirement. The therapist removed 
the task and attention for 30 seconds when a disruptive 
behavior occurred. During the time out, the therapist 
averted his face and positioned his arm and shoulder to 
block her efforts to pull his hair and scratch his face and 
used his leg to secure her chair. The therapist continued 
to present commands at 5- to 10-second intervals and 
provide praise (good job) for successful attempts when no 
disruptive behavior occurred. In order to limit her 
opportunities to misbehave, the table was placed beside the
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wall, the therapist's chair was positioned slightly behind 
Frankie, and the therapist removed glasses and other 
breakable items and wore long sleeves to protect his arms 
during the time out.
Joel. A task analysis of existing class rules was 
conducted to train the concepts of in-seat behavior, hand 
signaling for attention, waiting, and appropriate 
requesting. Differential reinforcement in the form of 
functional communication training (FCT) with graduated 
compliance was used to train Joel to say baba and signal 
with his hand to access a clear plastic bottle. After 
giving Joel 1-minute access to the bottle, it was removed, 
and he was trained to raise his hand to recruit the 
therapist's attention, wait appropriately in increments (5, 
10, 15, 20, 30 seconds), until a timer signaled the end of 
the interval, and then appropriately sign for the bottle 
when asked, "What do you want?" Behavioral interventions 
included a three-prompt sequence to manage out-of-seat 
behavior, verbal interruption for loud talk-outs, and 
ignoring all quiet self-talk or movements not disruptive to 
the task.
Mark. Mark's academic task was identical to Joel's. 
Differential reinforcement with graduated compliance was 
used to train Mark to appropriately signal for attention 
(How do you ask?), verbally request his toy guitar (What do 
you want?), and wait appropriately in increments (5, 10,
15, 20, 30 seconds) until a timer signaled the end of the
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wait interval. Behavioral interventions included guided 
compliance to manage out-of-seat behavior, verbal reprimand 
for loud talk-outs, and ignoring all quiet self-talk or 
movements not disruptive to the task.
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RESULTS
Phase 1: Functional Analysis 
Figure 1 shows the results of the functional analysis 
for Cade (upper panel) and Frankie (lower panel) and figure 
2 shows the results for Joel (upper panel), Mark (middle 
panel) and Cooper (lower panel). For all children, data are 
plotted as the percentage of intervals of disruptive 
behavior (e.g., calling out, throwing or tearing objects, 
leaving seat, hitting, kicking, or pinching others, 
throwing or tearing objects, hitting self) across sessions.
For Cade, disruptive behavior occurred at high and 
stable levels during the alone condition (mean, 94%; range, 
90% to 100%). Relatively low levels of disruptive behavior 
occurred during the attention condition (mean, 4%; range,
2% to 7%). No disruptive behavior occurred during the 
demand condition and low levels were recorded during the 
control condition (mean, 2%; range, 0% to 3%). Based on 
these results, Cade's disruptive behavior did not appear to 
be maintained by socially-mediated reinforcement.
For Frankie, disruptive behavior occurred at high and 
stable levels during the alone condition (mean, 93%; range, 
83% to 100%). Moderate and stable levels of disruptive 
behavior occurred during the attention condition (mean,
39%; range, 27% to 48%). Disruptive behavior was reduced in 
the demand condition (mean, 12%; range, 3% to 25%) and in 
the control condition (mean, 1%; range, 0% to 4%). Thus, 
the results for this analysis suggested that disruptive
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Figure 1. Percentage of intervals of disruptive behavior 
across functional analysis conditions (alone, demand, 
control, attention) for Cade (upper panel) and Frankie 
(lower panel).
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Figure 2. Percentage of intervals of disruptive behavior 
across functional analysis conditions (alone, attention, 
control, demand, tangible) for Joel (upper panel), Mark 
(middle panel), and Cooper (lower panel).
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behavior was most likely related to socially mediated 
reinforcement in the form of attention or some unknown 
variable associated with the alone condition.
For Joel, disruptive behavior occurred at high levels 
in the alone condition (mean, 78%; range, 52% to 93%), 
relatively low but variable levels in the attention (mean, 
6%; range, 0% to 12%), tangible (mean, 7%; range, 0% to 
22%), demand (mean, 1%; range, 0% to 2%), and control 
(mean, 6%; range, 0% to 23%) conditions. Based on these 
results, Joel's disruptive behavior did not appear to be 
maintained by socially-mediated reinforcement.
For Mark, disruptive behavior occurred at high levels 
in the alone condition (mean, 81%; range, 58% to 9 3%) and 
moderate levels in the attention (mean, 26%; range, 25% to 
28%) and tangible (mean, 16%; range, 14% to 19%) 
conditions. Disruptive behavior levels were low and stable 
in the demand (mean, 1%; range, 0% to 2%) and control 
(mean, 0%) conditions. These results indicated the 
disruptive behavior was highest in the alone condition but 
was also responsive to socially mediated positive 
reinforcement in the form of attention and tangible items.
For Cooper, disruptive behavior was high and stable in 
the alone condition (mean, 96%; range, 90% to 97%) and 
attention condition (mean, 86%; range, 77% to 97%). 
Disruptive behavior was moderate to high during the demand 
(mean, 39%; range, 6% to 65%) and tangible (mean, 57%; 
range, 50% to 71%) conditions, and low and stable during
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the control condition (mean, 10%; range, 0% to 18%). Thus, 
the results for this analysis might be considered either 
multiple controlled or undifferentiated. The level of 
disruptive behavior was highest in the alone condition, was 
responsive, to a lesser degree, to positive reinforcement 
in the form of attention or tangible items, and remained 
low during the control condition.
Table 6 shows the task performance results for all
children during the demand, attention, and alone 
conditions.
Table 6. Analog Performance Measures across Conditions
Child Measures Demand Attention Alone
Cade Mean Task Completion 35 23 12
Percent Correct 39% 0% 0%
Frankie Mean Task Completion 52 0 0
Percent Correct 37% 0% 0%
Joel Mean Task Completion 44 1 1
Percent Correct 62% 0% 0%
Mark Mean Task Completion 51 8 7
Percent Correct 49% 26% 31%
Cooper Mean Task Completion 39 17 0
Percent Correct 48% 18% 0%
Overall, the results indicated that each child's 
target behavior persisted at the highest rate in the alone 
condition. Behavior that persists at high levels in the 
absence of socially mediated consequences is more likely to 
be responsive to treatment with medication. For three of 
the children, the results suggested that target behaviors 
might also be responsive to positive reinforcement in the 
form of attention or tangible items to various degrees. 
Thus, the no interaction and attention conditions appeared
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to be appropriate functional assessment conditions to 
evaluate the effects of MPH and placebo in classroom 
settings.
Phase 2: Medication Evaluation 
Classroom Functional Analysis 
Two functional analysis conditions (attention, no 
interaction) were first conducted in the regular classroom 
when the child was not receiving medication to further 
determine baseline levels of disruptive behavior and task 
engagement as compared to analog conditions. The no 
interaction condition was used as the classroom equivalent 
of the analog functional analysis alone condition. For all 
children, the percentage of intervals in which disruptive 
behavior occurred were collected during baseline, when 
receiving no medication, and across each dosage and placebo 
in the attention (top panel of Figures 3 through 7) and no 
interaction (lower panel of Figures 3 through 7) 
conditions.
Cooper. Figure 3 shows disruptive behavior levels 
during Cooper's medication evaluation. During baseline, 
disruptive behavior occurred at high rates with an 
increasing trend in the attention (mean, 79%; range, 61% to 
100%) condition sessions and in 100% of the intervals 
during the no interaction condition sessions. Disruptive 
behavior was high in the attention condition when Cooper 
received either placebo (mean, 66%; range, 25% to 92%) or 
10 mg of MPH (mean, 70%; range, 3% to 98%). During the no
83
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Figure 3. Percentage of intervals of disruptive behavior 
in baseline and across each dosage compared to placebo 
in the attention (upper panel) and no interaction (lower 
panel) conditions of Cooper's medication evaluation.
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interaction condition, disruptive behavior occurred at 
high, stable rates when Cooper received either 10 mg of MPH 
(mean, 96%; range, 90% to 100%) or placebo (mean, 90%; 
range, 60% to 100%).
The physician reviewed all results and recommended 
increasing Cooper's dosage to a medium level of 15 mg of 
MPH and a placebo to alternate every two days for eight 
days. Alternating every 2 days was selected to minimize 
possible multiple treatment interference effects. When 
Cooper received the medium dose, disruptive behaviors 
decreased quickly and occurred at relatively low and stable 
levels during both the attention (mean, 16%; range, 2% to 
55%) and no interaction (mean, 32%; range, 0% to 100%) 
conditions. Disruptive behavior remained at baseline levels 
when Cooper received placebo in the attention (mean, 77%; 
range 42% to 97%) and no interaction (mean, 95%: range, 63% 
to 100%) conditions.
After reviewing all results, the physician determined 
the 15 mg dose of MPH was effective for Cooper and 
recommended terminating the medication evaluation.
Cade. Figure 4 shows the results of Cade's medication 
evaluation. During baseline, disruptive behavior was 
moderately high during the attention (mean, 55%; range, 53% 
to 60%) and no interaction (mean, 45%; range, 41% to 50%) 
condition sessions.
Disruptive behavior was moderately high with a 
downward trend in the attention condition when Cade
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Figure 4. Percentage of intervals of disruptive behavior 
in baseline and across each dosage compared to placebo 
in the attention (upper panel) and no interaction (lower 
panel) conditions of Cade's medication evaluation.
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received placebo (mean, 16%; range, 3% to 25%) and 
moderately high and variable when he received 5 mg of MPH 
(mean, 20%; range, 7% to 55%). During the no interaction 
condition, disruptive behavior occurred at similar rates 
when he received 5 mg of MPH (mean, 53%; range, 8% to 87%) 
or placebo (mean, 54%; range, 11% to 91%). Disruptive 
behavior decreased below baseline levels and was showing a 
downward trend when receiving either placebo or 5 mg of 
MPH. The downward trend for placebo is unusual, and it is 
possible that unexplained sequence effects or multiple 
treatment interference may have occurred.
The physician reviewed all results and recommended 
increasing Cade's dosage to a medium level of 10 mg of MPH 
and a placebo to alternate every two days for eight days. 
Disruptive behaviors occurred at a lower and more stable 
rate when Cade received 10 mg of MPH (mean, 12%; range, 7% 
to 17%) as compared to placebo (mean, 46%; range 32% to 
57%). In the no interaction condition, disruptive behavior 
occurred at a lower but more variable rate when Cade 
received 10 mg of MPH (mean 36%; range 7% to 83%) as 
compared to placebo (mean, 82%; range, 52% to 97%). The 
medium dose appeared to stabilize disruptive behavior more 
quickly during the attention condition than during the no 
interaction condition; however, disruptive behavior did 
show a downward trend when Cade received 10 mg of MPH in 
the no interaction condition. At the end of the evaluation 
phase, disruptive behavior was on a downward trend when
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Cade received 10 mg of MPH and an upward trend with 
placebo.
After reviewing all results, the physician determined 
the 10 mg dose of MPH was effective for Cade and 
recommended terminating the medication evaluation.
Frankie. Figure 5 shows the results of Frankie's 
medication evaluation. During baseline, disruptive behavior 
occurred at high rates with increasing trends in the 
attention (mean, 86%; range, 67% to 100%) and no 
interaction (mean, 92%; range, 78% to 100%) condition 
sessions.
Disruptive behavior occurred at high and variable 
rates during the attention condition when Frankie received 
5 mg of MPH (mean, 59%; range, 40% to 72%), and at high 
rates with an increasing trend when she received placebo 
(mean, 56%; range 32% to 83%). During the no interaction 
condition, disruptive behavior occurred at high rates with 
an increasing trend when she received 5 mg of MPH (mean, 
81%; range, 59% to 94%) and at high rates with a decreasing 
trend when she received placebo (mean, 84%; range, 68% to 
9 3%). The downward trend for placebo in the no interaction 
condition is unusual and contradicts the downward trend 
shown with MPH and upward trend with placebo in the 
attention condition over the same days. It is possible that 
unexplained sequence effects or multiple treatment 
interference may have occurred.
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Figure 5. Percentage of intervals of disruptive behavior in 
baseline and across each dosage compared to placebo in the 
atention (upper panel) and no interaction (lower panel) 
conditions of Frankie’s medication evaluation.
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The physician reviewed all results and recommended 
increasing Frankie's dosage to a medium level of 10 mg of 
MPH and a placebo to alternate every two days for eight 
days. During the attention condition, disruptive behavior 
was moderately high with a variable but downward trend when 
Frankie received 10 mg of MPH (mean 41%; range, 13% to 
82%). Disruptive behavior occurred at a higher rate when 
she received placebo (mean, 81%; range, 61% to 94%). During 
the no interaction condition, disruptive behavior occurred 
at highly variable rates when she received 10 mg of MPH 
(mean, 65%; range, 15% to 100%) and high and stable rates 
with placebo (mean, 89%; range, 78% to 100%) .
The physician reviewed all results and recommended 
increasing Frankie's dosage to a high level of 15 mg of MPH 
to alternate every two days for eight days. During the 
attention condition, disruptive behavior levels decreased 
in the attention condition when she received 15 mg of MPH 
(mean, 24%; range, 7% to 53%) as compared to placebo (mean, 
73%; range, 40% to 100%). During the no interaction 
condition, disruptive behavior showed a downward but 
somewhat varied rate when she received 15 mg of MPH (mean, 
24%; range, 3% to 58%) and was significantly reduced 
compared to placebo (mean, 72%; range, 32% to 97%) at the 
15 mg dose.
After reviewing all results, the physician determined 
the 15 mg dose of MPH was effective for Frankie and 
recommended terminating the medication evaluation.
90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Joel. Figure 6 shows the results of Joel's medication 
evaluation. During baseline, disruptive behavior occurred 
at moderately high levels with an increasing trend in the 
attention condition (mean, 39%; range, 17% to 83%) and high 
levels with an increasing trend in the no interaction 
condition (mean, 63%; range, 17% to 9 3%).
In the attention condition, disruptive behavior levels 
were moderately low and stable when Joel received 10 mg of 
MPH (mean, 14%; range, 8% to 22%) or placebo (mean, 13%; 
range, 7% to 17%) . During the no interaction condition, 
disruptive behavior was moderately low and showed 
decreasing trends when Joel received 10 mg of MPH (mean, 
33%; range, 13% to 58%) or placebo (mean, 27%; range, 17% 
to 45%). Disruptive behavior levels decreased compared to 
baseline when Joel received either 10 mg of MPH or placebo 
in both the attention and no interaction conditions.
The physician reviewed all results and recommended 
increasing Joel's dosage to a medium level of 15 mg of MPH 
to alternate every two days for eight days. During the 
attention condition, disruptive behavior levels increased 
and became highly variable when Joel received 15 mg of MPH 
(mean, 24%; range, 2% to 73%) but remained low and 
relatively stable when he received placebo (mean, 15%; 
range 2% to 85%). During the no interaction condition, 
disruptive behavior occurred at moderate and variable rates 
when he received either 15 mg of MPH (mean, 37%; range, 0% 
to 73%) or placebo (mean, 35%; range, 3% to 70%).
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Figure 6. Percentage of intervals of disruptive behavior 
in baseline and across each dosage compared to placebo in 
the attention (upper panel) and no interaction (lower 
panel)conditions of Joel's medication evaluation.
92
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
After reviewing all results, the physician determined 
the 15 mg dose of MPH was also ineffective for Joel and 
recommended terminating the medication evaluation.
Mark. Figure 7 shows the results of Mark's medication 
evaluation, During baseline, disruptive behavior levels 
were moderately high in the attention condition (mean, 28%; 
range, 20% to 35%) and high in the no interaction condition 
(mean, 7 0%; range, 55% to 87%).
During the attention condition, disruptive behavior 
occurred at moderately low and stable levels in the 
attention condition when he received 10 mg of MPH (mean, 
14%; range, 2% to 25%) and at somewhat higher but stable 
levels when he received placebo (mean, 20%; range 13% to 
33%). During the no interaction condition, disruptive 
behavior occurred at higher levels when he received 10 mg 
of MPH (mean, 62%; range, 0% to 94%) than when he received 
placebo (mean, 46%; range, 36% to 63%). In both conditions, 
disruptive behavior was lower than baseline with a downward 
trend when Mark received placebo and higher than baseline 
with an upper trend when he received MPH. These results are 
unusual and may be related to unexplained sequence effects 
or multiple treatment interference.
The physician reviewed the results and recommended 
increasing Mark's dosage to a medium level of 15 mg of MPH 
and a placebo to alternate every two days for eight days. 
Disruptive behavior occurred at higher rates with an 
increasing trend when Mark received the 15 mg dose of MPH
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Figure 7. Percentage of intervals of disruptive behavior 
in baseline and across each dosage compared to placebo in 
the attention (upper panel) and no interaction (lower 
panel) conditions of Mark’s medication evaluation.
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(mean, 31%; range, 0% to 75%) and at lower levels with a 
downward trend when he received placebo (mean, 13%; range 
5% to 32%). During the no interaction condition, disruptive 
behavior occurred at high and variable levels when he 
received 15 mg of MPH (mean, 69%; range, 0% to 100%) and a 
lower level when he received placebo (mean, 40%; range, 2% 
to 100%).
After reviewing all results, the physician determined 
the 15 mg dose of MPH was also not effective for Mark and 
recommended terminating the medication evaluation.
Task Engagement
Table 7 gives the levels of task engagement for each 
child across dosages of MPH and placebo in each condition 
of the classroom functional analysis assessments.
Engagement was undifferentiated between low dose of MPH and 
placebo in the attention condition for all children. 
Engagement improved with the increase in MPH dose over 
placebo for Cooper, Cade, and Frankie and remained 
essentially unchanged for Joel and Mark. There was a small 
decrease in engagement in the attention condition when 
Frankie moved to the highest dose of MPH. Joel and Mark's 
task engagement were higher when they received placebo than 
when they received the medium dose of MPH.
The effects of MPH were not as significant in the no 
interaction condition for task engagement; however, Cooper, 
Cade, and Frankie showed some improvement from the low to 
medium dose. Task engagement decreased for Joel and Mark
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Table 7. Mean Percentage of Intervals for Task Engagement across MPH Dosage and Placebo 
for the Attention (ATT) and No Interaction (NI) Conditions
Child Low
Mean
Dose
Range
Placebo 
Mean Range
Medium Dose 
Mean Range
Placebo 
Mean Range
High Dose 
Mean Range
Placebo 
Mean Range
Cooper ATT 29 0-92) 33 4-75) 62 12-98) 18 3-45) N/A N/A
NI 3 0-12) 8 0-32) 20 0-100) 8 0-61) N/A N/A
Cade ATT 76 45-92) 79 65-97) 83 75-90) 63 40-92) N/A N/A
NI 46 13-92) 45 5-88) 67 17-93) 16 2-50) N/A N/A
Frankie ATT 31 25-37) 42 17-62) 56 33-82) 20 6-39) 49 (23-72) 11 ( 0-30)
NI 19 6-42) 10 3-18) 39 0-85 11 0-17) 38 ( 4-97 11 ( 2-43)
Joel ATT 77 62-90) 82 70-90) 72 38-97) 85 67-98) N/A N/A
NI 60 38-82) 71 58-83) 58 16-100) 45 2-97) N/A N/A
Mark ATT 74 27 -98) 79 66-87 68 25-100 85 72-95) N/A N/A
NI 30 5-93) 48 36-64) 28 0-80) 59 0-80) N/A N/A
from the low to medium dose. Task engagement was higher for 
Mark when he received placebo than when he received either 
the low or medium doses of MPH. Task engagement remained 
stable in both conditions when Frankie received MPH and 
placebo in the high dose evaluation.
Performance Measures 
Table 8 gives the performance measures collected 
during the classroom functional analysis conditions when 
the children were receiving MPH. The data were analyzed in 
conjunction with data collected during the functional 
analysis analogs (see Table 6) and used to develop the 
interventions in the final phase of the study.
Table 8. Classroom Functional Analysis Performance Measures
Child Measures Attention No Interaction
Cooper Mean Task Completion 31 3
Percent Correct 13% 0%
Cade Mean Task Completion 40 13
Percent Correct 1 1%
Frankie Mean Task Completion 16 0
Percent Correct 0% 0%
Joel Mean Task Completion 6 6
Percent Correct 6% 0%
Mark Mean Task Completion 30 20
Percent Correct 9% 0%
Cade completed more tasks in the attention condition 
than during the interaction condition. There was no 
difference in task accuracy (percent correct) between the 
conditions.
Cooper's task completion was higher in the attention 
condition. Task accuracy improved in the attention 
condition.
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Frankie's task completion was higher in the attention 
condition. Frankie completed no task correctly in either 
condition.
Joel completed an equal number of tasks in both 
conditions. He was more accurate during the attention 
condition.
Mark's mean number of completed tasks was higher in 
the attention condition. His accuracy was slightly improved 
in the attention condition.
Behavior Rating Scales
Table 9 shows the rating scores given by the teachers 
and support workers for each of the children when they 
received placebo and low, medium, or high dose of MPH. 
Across all scales some of the highest scores were given to 
Mark when he received placebo and all dosages of MPH even 
though the direct observations indicated he did not respond 
to MPH. Joel also received consistently high scores when he 
received placebo and all dosages of MPH on almost all 
scales. For Cade, Cooper, and Frankie, CAP scores were 
higher or essentially the same as baseline scores across 
all dosages of MPH. The HSQ-R and SSQ-R scales generated 
low scores across all dosages and placebo for all children 
except Mark. For Mark, the HSQ-R and SSQ-R generated 
moderately high to high scores across all dosages and 
placebo.
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Table 9. Mean Teacher and Support Worker Behavior Rating Scale Scores
Cade
Placebo MPH
Cooper 
Placebo MPH
Frankie 
Placebo MPH
Joel
Placebo MPH
Mark
Placebo MPH
CAP/ Support Worker
Baseline 63 N/A 21 N/A 30 N/A 39 N/A 100 N/A
Low-dose Evaluation 28 57 13 19 0 17 66 52 100 107
Medium-dose Evaluation 53 40 15 20 29 20 64 44 70 96
High-dose Evaluation N/A N/A N/A N/A 30 33 N/A N/A N/A N/A
CAP/ Teacher Form
Baseline 36 N/A 67 N/A 65 N/A 9 N/A 108 N/A
Low-dose Evaluation 3 31 54 56 63 27 63 30 104 60
Medium-dose Evaluation 36 40 48 10 44 43 23 35 64 93
High-dose Evaluation N/A N/A N/A N/A 59 38 N/A N/A N/A N/A
HSQ-R/ Support worker
Baseline 33 N/A 11 N/A 1 N/A 7 N/A 16 N/A
Low-dose Evaluation 20 26 0 0 0 6 20 29 50 71
Medium-dose Evaluation 24 24 12 7 8 6 17 24 55 39
High-dose Evaluation N/A N/A N/A N/A 21 27 N/A N/A N/A N/A
SSQ-R/ Teacher
Baseline 14 N/A 5 N/A 38 N/A 15 N/A 72 N/A
Low-dose Evaluation 3 18 18 18 30 8 38 29 59 42
Medium-dose Evaluation 18 14 19 3 22 19 11 17 27 44
High-dose Evaluation N/A N/A N/A N/A 12 4 N/A N/A N/A N/A
SDSERS/ Support Worker
Baseline 69 N/A 20 N/A 23 N/A 34 N/A 40 N/A
Low-dose Evaluation 31 37 14 26 0 23 85 65 61 112
Medium-dose Evaluation 42 9 11 18 31 25 59 51 56 27
High-dose Evaluation N/A N/A N/A N/A 47 39 N/A N/A N/A N/A
SDSERS/ Teacher
Baseline 16 N/A 29 N/A 17 N/A 27 N/A 63 N/A
Low-dose Evaluation 2 24 34 37 26 6 46 30 23 15
Medium-dose Evaluation 7 17 10 9 9 26 0 9 3 5
High-dose Evaluation N/A N/A N/A N/A 12 5 N/A N/A N/A N/A
The Intervention Rating Profile-15 (IRP-15)
The IRP-15 acceptability rating was given to the 
teacher and primary direct support worker (DSW) prior to 
and following implementation of the medication and 
behavioral treatment evaluations for each child. Table 10 
gives the results of the pre- and post-treatment measures 
for the children.
Overall teacher acceptability ratings of the 
medication intervention corresponded with the medication 
evaluations for each child; however, teacher behavioral 
intervention ratings did not correspond with the direct 
observations made of these treatments. Following the 
medication evaluation, teacher acceptability ratings for 
the medication intervention improved for Cade, Cooper, and 
Frankie and decreased for Joel and Mark. Teacher 
acceptability ratings for the behavioral intervention 
increased for Cooper and Frankie, did not change for Cade, 
and decreased for Joel and Mark.
Table 10. Intervention Acceptability Ratings for Medication 
and Behavioral Treatments
Cade Cooper Frankie Joel Mark
Medication Pre Post Pre Post Pre Post Pre Post Pre Post
Teacher 53 75 73 100 94 98 63 57 94 50
DSW 61 89 83 91 63 66 73 70 77 89
Behavior Pre Post Pre Post Pre Post Pre Post Pre Post
Teacher 60 60 37 81 96 100 74 46 97 23
DSW 92 92 61 91 78 78 46 89 63 89
Support worker acceptability ratings of the medication 
intervention corresponded with the medication evaluations 
for all children except Mark. The support worker 
post-intervention ratings were higher for the medication
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intervention for Cade, Cooper, Frankie, and Mark, and 
decreased for Joel. The support worker medication 
post - treatment ratings for Mark increased even though the 
medication evaluation indicated the MPH was not effective. 
Post-treatment support worker acceptability ratings for the 
behavioral interventions generally supported the treatment 
evaluations for all children but Frankie.
Phase 3: Treatment Evaluation
Behavioral treatments to reduce disruptive behavior
and increase task engagement were developed after analyzing
the levels of disruptive behavior, task engagement, and
performance measures across the analog and classroom
functional analysis condition sessions. In phase 3, the
three children who responded to MPH received the following
four treatments: (a) the optimal dose of MPH alone (no
behavioral intervention), (b) MPH plus the behavioral
intervention, (c) the behavioral intervention with no pill,
and (d) behavioral intervention plus placebo. For the two
children not responding to MPH, a behavioral intervention
was developed targeting the behavioral deficits observed
during the functional analog and classroom conditions.
Behavioral and Medication Treatments for Children
Responding to MPH
Medication and Behavioral Treatment Evaluations
Figure 8 shows the results of the treatment
evaluations made in phase 3 for the three children for whom
an effective dose of MPH was established. The levels of
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Figure 8. Percentage of intervals of disruptive behavior in 
baseline attention (ATTN) condition compared to 
Methylphenidate (MPH) and behavioral treatments for Cade 
(upper panel), Cooper (middle panel), and Frankie (lower 
panel). Behavior treatment was differential reinforcement 
of alternative behavior (DRA) and graduated compliance (GC) 
with a time out (TO) intervention for disruptive behavior.
102
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
disruptive behavior in the baseline attention condition 
(left panel) is compared to disruptive behavior levels when 
the children received MPH or behavioral treatment alone for 
Cade (upper right panel), Cooper (middle right panel), and 
Frankie (lower right panel).
Cade. Figure 8 shows Cade's baseline levels of 
disruptive behavior in the classroom attention condition 
were moderately high and stable (mean, 55%; range 53% to 
60%). Disruptive behavior was reduced when Cade received 
MPH alone (mean, 16%; range, 8% to 25%) and the behavioral 
treatment alone (mean, 19%; range, 11% to 38%); however, 
both treatments were equally successful in reducing 
disruptive behavior to a stable and relatively low rate.
Cooper. Figure 8 shows Cooper's baseline level of 
disruptive behavior (mean, 79%; range, 61% to 100%) was 
high and increasing in the attention condition. Disruptive 
behavior was significantly low and stable when he received 
MPH alone (mean, 3%; range, 0% to 10%) and was stable and 
higher than baseline levels when only a behavioral 
treatment was used (mean, 87%; range, 80% to 95%).
Frankie. Figure 8 shows Frankie's baseline levels of 
disruptive behavior in the classroom attention condition 
were high with an increasing trend (mean, 86%; range, 67% 
to 100%) during the attention condition. Disruptive 
behavior was reduced in the MPH alone (mean, 25%; range, 5% 
to 42%) and the behavioral treatment alone condition (mean, 
39%; range, 30% to 44%). MPH initially reduced disruptive
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behavior to a low level; however, there was an increasing 
trend over the four doses.
Effects of Behavioral Treatment Alone and with MPH
Table 11 gives the results of the MPH plus behavioral 
treatment (MPH + BT) and behavioral treatment plus placebo 
(BT + Placebo) conditions on disruptive behavior and task 
engagement for the three children for whom an effective MPH 
dose was established.
Table 11. Disruptive and Engagement Behavior Percentage 
Means across Treatments
MPH
Disruptive
+ BT
Engagement
BT + 
Disruptive
Placebo
Engagement
Mean% 
Cade 15
Range
7-30
Mean%
84
Range
73-88
Mean%
16
Range
7-32
Mean%
74
Range
53-82
Cooper 13 0-33 95 88-100 66 28-100 42 0-93
Frankie 44 32-62 85 74-98 57 39-67 90 89-92
For Cade, combining behavioral treatment with either 
placebo or MPH had similar effects on disruptive behavior 
levels; however, task engagement increased when he received 
MPH and behavioral treatment. For Cooper, disruptive 
behavior decreased and task engagement increased when he 
received MPH rather than placebo during the behavioral 
treatment. For Frankie, disruptive behavior decreased in 
the MPH plus behavioral treatment condition; however, there 
was a slight decrease in task engagement when she received 
MPH rather than placebo with the behavioral treatment.
Task Engagement
Table 12 shows the mean levels of task engagement 
maintained by Cade, Cooper, and Frankie during baseline, 
during MPH alone conditions, and during behavioral
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treatment conditions (i.e., with placebo, with no pill). 
Both treatments increased task engagement for all three 
children; however, MPH alone was more effective in 
increasing task engagement than the behavioral intervention 
alone.
Table 12. Task Engagement for Treatments Compared to 
Baseline for Children Responding to MPH_____________________
Child Baseline 
Mean Range
MPH Behavioral 
Mean Range Mean
. Treatment 
Range
Cade 46% 40%- 50% 77% 7 0%- 87 % 56% 49%-67%
Cooper 20% 0%- 44% 100% 100% 44% 17 % - 85%
Frankie 11% 0%- 25% 88% 83%-100% 73% 58% - 84%
Behavioral Treatment Evaluations for Children 
Who Did Not Respond to MPH
Behavioral Treatment Results
Figure 9 shows the results of the phase 3 treatment 
evaluations for the two children for whom an effective dose 
of MPH was not established. The levels of disruptive 
behavior in the baseline attention condition (left panel) 
is compared to disruptive behavior levels when the children 
received a function-related behavioral treatment for Joel 
(right upper panel) and Mark (right lower panel).
Joel. Figure 9 shows Joel's baseline level of 
disruptive behavior in the attention condition (mean, 39%; 
range, 17% to 83%) was moderately high with an upward 
trend. Disruptive behavior occurred at stable and low rates 
when Joel received a behavioral treatment (mean, 4%; range, 
0% to 9%) .
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Figure 9.Percentage of intervals of disruptive behavior in 
baseline attention (ATTN) condition compared to behavioral 
treatments. For Joel (upper panel), behavioral treatment 
was functional communication training (FCT) with verbal 
reprimand for disruptive behavior. For Mark (lower panel), 
behavior treatment was differential reinforcement of 
alternative behavior (DRA) and graduated compliance (GC) 
with verbal reprimand for disruptive behavior.
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Mark. Figure 9 shows Mark's baseline level of 
disruptive behavior in the attention condition (mean, 28%; 
range, 20% to 35%) was moderately high and stable. 
Disruptive behavior occurred at stable and low rates when 
Mark received a behavioral treatment (mean, 4%; range, 0% 
to 14%).
Task Engagement during Behavioral Treatment
Table 13 shows the mean levels of task engagement 
maintained by Joel and Mark during baseline and behavioral 
treatments. Task engagement increased significantly for 
Joel and marginally for Mark.
Table 13. Task Engagement Percentage Means and Ranges for 
Joel and Mark's Behavioral Treatments
Child Baseline Behavioral Treatment
Mean Range Mean Range
Joel 35% 0% - 68% 93% 86% - 100%
Mark 72% 67% - 78% 85% 53% - 100%
Performance Measures
Table 14 shows the performance measures collected 
during the phase 3 treatments. The data can be compared to 
the measures collected in the functional analysis analogs 
(Table 6) and classroom functional assessments (Table 8) to 
compare task productivity (mean task completion) and 
accuracy (percent correct) across treatments.
MPH and behavioral treatment had similar effects on 
Cade's productivity; however, productivity increased when 
the treatments were combined (MPH+BT). Accuracy was higher 
with MPH than with behavioral treatment but was highest 
when the two treatments were combined.
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Table 14. Performance Measures across Treatment Conditions
Child " Measures MPH BT MPH+BT
Cade Mean Task Completion 27 26 35
Percent Correct 43% 39% 63%
Cooper Mean Task Completion 94 16 83
Percent Correct 97% 45% 99%
Frankie Mean Task Completion 7 3 4
Percent Correct 27% 67% 88%
Joel Mean Task Completion N/A 46 N/A
Percent Correct N/A 93% N/A
Mark Mean Task Completion N/A 40 N/A
Percent Correct N/A 79% N/A
Cooper's productivity was highest with MPH and lowest
with behavioral treatment. Combined treatments had a lower 
task completion rate than MPH alone. Accuracy was higher 
when he received MPH than behavioral treatment. Combining 
the treatments showed minimal improvement; however, a 
ceiling effect may have been in place.
Frankie's productivity was highest in the MPH 
condition but low across all treatments. Accuracy was low 
with MPH, increased with the behavioral treatment, and 
increased again when the treatments were combined.
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DISCUSSION
The current study uses a three-phase, individualized 
assessment with multiple behavior measures across several 
domains to determine individual medication effects for five 
children with severe to profound mental retardation. This 
study also demonstrates the utility of a single-subject 
design and functional analysis in determining the separate 
and combined effects of stimulant medication and behavioral 
treatments on disruptive behavior and task engagement for 
individual participants.
In the first phase, the analog functional analyses for 
each child showed that the highest levels of disruptive 
behavior occurred in the alone and attention conditions.
The results identified two children with disruptive 
behaviors that did not appear to be influenced by any 
socially mediated reinforcement. Disruptive behaviors 
appeared most likely related to socially mediated 
reinforcement in the form of attention or some unknown 
variable associated with the alone condition for the 
remaining three children.
The second phase used direct classroom observation and 
behavior rating scales to evaluate MPH-related changes in 
disruptive behavior and task engagement in attention and no 
interaction conditions within a multielement design. 
Positive effects for MPH were found for three of the five 
children (i.e., reductions in disruptive behavior 
concurrent with increased levels of task engagement).
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The third phase investigated the separate and combined 
effects of MPH and behavioral interventions for three of 
the children and behavioral treatment alone for the two 
children not responding to MPH. The results suggest that 
there were individual medication and behavioral treatment 
effects for these children.
The majority of the studies evaluating MPH treatment 
effects have targeted children with average intelligence, 
used subjective care provider reports and behavior rating 
scales, reported results based on between-group statistical 
analyses, and limited assessments to one area of 
functioning (Gulley & Northup, 1997). A limited number of 
stimulant medication efficacy studies with children with 
ADHD and average intelligence have combined a 
single-subject experimental design, standardized drug 
evaluation procedures, and multiple behavioral assessment 
measures across dosages (Gulley & Northup, 1997; Northup, 
et al., in press; 1999).
A small number of methodologically sound, 
single-subject designs have compared MPH to behavioral 
treatments for children with mental retardation (Ayllon et 
al., 197 5; Pelham et al., 19 80, Shafto & Sulzbacher, 1977; 
Wulbert &. Dries, 1977) . Two studies have used 
single-subject designs to make controlled comparisons of 
baseline conditions, a behavioral intervention alone, and 
the combination of MPH and a behavioral intervention for 
the treatment of disruptive behavior in children with mild
110
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
to moderate mental retardation (Schell et al., 19 86;
Johnson et al., 1994). Blum et al. (1996) targeted the 
disruptive behaviors of children with severe to profound 
mental retardation in a single-subject experimental design 
with a significantly large number of data points over 
multiple medication conditions to document the simple and 
combined beneficial effects of stimulants and behavioral 
treatments.
This study extends Blum et al. (1996) by using a
single-subject design and functional analysis to evaluate 
the effects of MPH and behavioral treatment for 5 children. 
This study also extends the Gulley and Northup (1997) and 
Northup et al. (1999; in press) classroom evaluations of
MPH effects for children with average intelligence and ADHD 
to children with severe to profound mental retardation and 
disruptive behavior. As with these earlier studies, this 
protocol systematically assesses a variety of behaviors 
(e.g., disruptive classroom behaviors, engagement, 
performance) and uses several methods (e.g., behavior 
scales, direct observations, preference assessments, 
functional analyses).
A limited number of stimulant efficacy studies have 
included behavioral treatments based on functional analysis 
(Cooper et al., 1993; Fisher et al., 1989; Kayser et al., 
1997; Northup et al., 1999; in press). This study used 
functional analysis to describe medication effects on 
specific classroom behaviors as well as to determine
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effective function-related behavioral treatments. Analog 
data were used to select pertinent controlled conditions 
for classroom evaluation of MPH effects. Thus, this study- 
replicated the use of classroom functional analysis to 
establish the function of disruptive classroom behaviors 
and illustrated a strategy for evaluating the treatment 
effects of medication interventions across multiple 
behaviors (Northup et al., 1999; in press).
The Northup et al. (1999; in press) conclusions on 
drug-behavior interactions were based on analog conditions 
in a university lab setting. This study extends functional 
assessments directly into the child's actual classroom with 
instructional tasks taken from the child's current 
curriculum. The treatment evaluation (phase 3) also 
attempts to assess the more complex differential 
reinforcement programs associated with greater treatment 
effects in the literature.
Using an analog analysis to set up the classroom 
assessment conditions may be a useful protocol to identify 
components of behavioral and medication treatment packages 
for children with disruptive behaviors that do not clearly 
differentiate in traditional functional analysis. This 
method accomplishes an effective classroom analysis of 
medication effects and allows a more complete evaluation of 
within-subject effects.
Failure to control for antecedent and consequent 
events and contextual variables has been a major limitation
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in many previous drug studies conducted for persons with 
mental retardation (Aman & Singh, 1991). Thus, the 
functional analysis procedure used in this study provided 
controlled environmental conditions to evaluate MPH effects 
in the classroom. In phase 2, the children who responded to 
MPH displayed less disruptive behavior in both the no 
interaction and attention conditions when receiving an 
effective dose of MPH as compared to placebo. There did not 
appear to be any differential effect across the two types 
of consequences for any participant.
These results are consistent with previous studies 
that suggest MPH effects are most likely to be mediated by 
antecedent events (Northup et al., 1997; 1999; in press; 
Whalen et al., 1979, Wilkison, Kircher, McMahon, & Sloane, 
1995). For example, Northup et al. (1999; in press) showed 
teacher proximity to interact with MPH effects across 
ignore, reprimand, and time-out conditions. One possible 
explanation is that the discriminative properties of the 
adult were altered when the child received MPH.
Medication is frequently prescribed for the disruptive 
behavior of children with mental retardation; however, 
medication efficacy studies with this population should 
consider the degree to which the behavior is influenced by 
environmental conditions (Thompson et al., 1993) .
Functional analysis has proven utility in developing 
behavioral treatments for persons with mental retardation. 
This study suggests that similar functional analysis
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procedures should be considered when assessing medication 
treatments for this population (Baumeister et al., 1993; 
Blum et al., 1996) .
During the past 10 years, numerous between-group 
studies have validated stimulant use in the ADHD population 
for children with average intelligence and mild to moderate 
mental retardation; however, the between-group studies 
targeting children with severe to profound mental 
retardation have not demonstrated consistent positive 
effects. The cognitive and adaptive deficits of children 
with mental retardation make it more difficult to assess 
behavioral improvement and stimulant side effects. Direct 
observation of medication effects may be a more beneficial 
method for children with severe to profound mental 
retardation.
The treatment of choice for the disruptive behavior of 
children with mental retardation is generally medication 
prescribed by physicians and behavioral treatments 
developed by behavior analysts. Traditionally, the two 
disciplines have worked independently. Blum et al. (1996)
urged medical practitioners and behavior analysts to 
collaborate in order to more accurately monitor dose 
response and drug-behavior interactions. Physicians 
typically rely on subjective reports, whereas behavior 
analysts can collect objective data useful to treatment 
teams making pharmacological decisions.
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These results are also consistent with other studies 
that have shown positive medication effects may not always 
be apparent to the classroom teacher (e.g., Gulley and 
Northup, 1997). In this study, support worker ratings of 
MPH side-effects for Cade were highest during baseline when 
he received no pill as compared to direct observations 
which indicated reduced disruptive behavior and increased 
task engagement when he received MPH. Teachers rated 
Frankie's attentiveness and disruptive behavior low when 
she received either placebo or MPH. These results support 
previous suggestions that teacher and care provider reports 
are subject to informant bias (Stoner et al., 1994; Shapiro 
& Kratochwill, 19 88). Thus, teacher and parent ratings can 
be useful supplements to direct observations of relevant 
behavioral variables within the classroom setting and 
during academic tasks but have limited utility as repeated 
daily measures (Gulley & Northup, 1997) .
The care provider acceptability ratings deserve 
special mention. Poling and LeSage (1995) report 
acceptability ratings are important in assessing the social 
validity of psychotropic treatments. In this study, the 
post-treatment acceptability ratings for both the 
behavioral and medication interventions varied according to 
medication response. In general, post-treatment care 
provider ratings of both the medication and behavioral 
treatments improved for Cade, Cooper, and Frankie.
Post-treatment care provider ratings for Mark and Joel's
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behavioral treatments were inconsistent. Post-treatment 
teacher acceptability ratings for Joel and Mark's highly 
effective behavioral interventions decreased from 
pre-treatment acceptability ratings. Support worker 
acceptability ratings of MPH did not decrease even though 
neither child responded to MPH. Unlike the daily 
administered rating scales, the acceptability scales were 
only administered as pre- and post-treatment measures. 
Therefore, these results were not influenced by repetitive, 
daily ratings. In an effort to develop a standardized 
methodology, the same acceptability measure was adapted for 
both interventions. Future studies should consider 
developing separate measures for alternate treatments.
A number of procedural issues and limitations should 
be noted. First, the analog assessments were highest during 
the alone condition for all children and identified a 
likely environmental influence on disruptive behavior for 
two of the children. The behavioral treatments were limited 
to antecedent manipulations and attempts to identify 
effective competing reinforcers. Thus, the inability to 
identify a maintaining variable for the disruptive behavior 
that could be removed or modified limited the effectiveness 
of the behavioral treatment.
Second, this evaluation involved a large number of 
sessions (mean, 90; range, 7 8 to 120) and required that the 
therapist and one to two observers be available for thirty 
minutes one-hour after medication administration for each
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child. Additionally, the two, 10-minute, classroom 
conditions required approximately 30 minutes, twice daily, 
to set up and complete. The behavior interventions were 
labor intensive, and teacher implementation was not 
explored. Future research should explore a briefer 
assessment method (e.g., minute-by-minute analysis), a 
teacher inservice protocol, and follow-up booster sessions.
Placebo was alternated with MPH to control for 
observer bias and to rule out the possibility that the 
child might respond differently on "no pill" days. This 
alternating treatment procedure appears to have contributed 
to an unusual downward trend for placebo that was possibly 
related to unexplained sequence effects or multiple 
treatment interference; this effect was found at some dose 
levels for both the children that responded to medication 
and those that did not.
As noted by Thompson et al. (1993), drug efficacy 
studies including children with developmental delays should 
also assess behavior deficits that might be associated with 
the disruptive behavior. Joel and Mark's disruptive 
behaviors appear to have been related to deficits in basic 
communication skills and appropriate classroom behaviors 
(e.g., recruiting, waiting). Neither child benefitted from 
medication and their interventions did not require the more 
complex treatments generated from the functional analyses 
of the other children. In fact, their two 5-minute 
preference assessments were probably more beneficial in the
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development of their behavioral interventions than the 54 
functional analysis sessions. Future research is needed to 
develop a systematic protocol to identify, assess, and 
train necessary classroom behaviors (e.g., appropriate 
attention seeking, waiting skills) in this population.
The literature indicates children with severe to 
profound mental retardation are more likely to develop 
side-effects with stimulant medication use; however, the 
behavior rating scales used with the average-IQ ADHD 
population have limited utility with the children in this 
study. Rather than eliminating these children from future 
studies, researchers should develop operational definitions 
of behaviors commonly exhibited by children medicated with 
MPH (e.g., behavior tics, social withdrawal) and make 
brief, controlled observations in natural settings during 
medication trials.
To summarize, this study has extended a growing body 
of behavioral analytic research that evaluates stimulant 
dosage effects on an individual basis using multiple 
assessment measures across several behavioral variables. It 
is the second study to use an experimental design to 
document beneficial effects of stimulants in children with 
severe to profound mental retardation (Blum et al., 1996).
The current study is unique in its use of functional 
analysis to assess medication effectiveness as well as 
develop appropriate behavioral treatments. Future research 
might include this method to evaluate the functional
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properties of problem behaviors in relation to medication 
status or develop a relatively practical and efficient 
model for assessing the simple and combined effects of MPH 
and function-related behavioral interventions within 
natural classroom settings.
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APPENDIX
CONSENT FORM
fUaflll________________ _________________________________________
A N D  A Q R I C U L T U R A L  A N D  M E C H A N I C A L  C O L L E G E  
Department ol Psychology 
236 Audubon Hall 
Baton Rouge, LA 70803-55011
PARENTAL PERMISSION FOR RESEARCH PARTICIPATION
Project Title: A Comprehensive Functional Assessment of the Effects of Methylphenidate on the Disruptive Behavior
of Children with Severe Mental Retardation
Performance Site: St. Maty Training School
Investigators: The following investigators are available for questions at the phone numbers below:
Name: Victoria Swanson John Northup, Ph.D.
LSU Dept of Psychology LSU Dept of Psychology
(318) 640-2501 (504) 388-4112
Purpose of Study: This is a research project designed to assist SL Mary Training School's psychology and medical
personnel in developing a comprehensive assessment procedure using multiple behaviors in a variety 
of settings (a) to determine an optimal dose, if any, of Ritalin, (b) to establish any differences in 
medication effects at various doses as well as across various child target aberrant behaviors, and (c) 
to assess academic or training performance, class or training room behavior, attention, social 
Interactions, and teacher or care provider ratings of child behavior. A methodology will be developed 
by which existing staff will be able to assess the usefulness of present medication status (medication, 
no medication) with children who have exhibited disruptive behavior or whose behavior has 
significantly impaired their educational and training progress.
Number of Participants: This study will include 5 to 8 children residing at SL Maiys Training School and currently
receiving methylphenidate (Ritalin).
Inclusion Criteria: The study includes children with severe to profound mental retardation, aged 6-18 years who have
been prescribed Ritalin for the treatment of disruptive and attentive behaviors in educational and/or 
training settings.
Exclusion Criteria: Children younger than 5 or older than 18, who are not enrolled at SL Mary's Training School, who
receive addWonal psychoactive medication, tor whom the facility does not currently have consent to 
administer Ritalin, and those children not previously referred to the Interdisciplinary team tor medication 
consideration will be excluded from this study.
Description of the Study: As a participant in this study, your child's care providers will be asked to complete
questionnaires, and participate in interviews. An initial functional analysis will be conducted 
when the child is not on medication, and will assist in determining the environmental events that 
may be affecting the disruptive behavior. Brief assessment observations will be made in 
situations which simulate problematic times for your child. For example, assessment situations 
will include accomplishing a training task, working one-on-one with a support provider, and 
when atone and unengaged. This information will be used to develop an effective behavior 
intervention. The child’s behavior will then be evaluated on and off medication in the classroom. 
This will be accomplished by administering the child various therapeutic doses of medication 
and a placebo (fake pill) on alternating days and evaluating his or her behavior in social, 
classroom, and one-on-one training situations. Direct observations and rating scales will be 
used to determine the most effective dose in each situation. The placebo assesses whether or 
not medication is as effective as medication without the child or care providers being aware that 
no medication has been given. This design uses a double blind procedure to ensure that 
participants, medteation givers, and observers are not influenced by prior knowledge of the 
research design. All participants will know the child received a pill prior to assessment; 
however, no one will know if the pill was a placebo or Ritalin. Thus, the medication will be
135
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
dspensed and packaged by the pharmacist in a coded order that only the prescribing 
physician will know. Ail doses will be the same color and each dose will be blister packed in a 
manner that doses cannot be confused by the nursing staff. At the end of each dose level 
assessment, the code will be broken by the prescribing physician and the assessments and 
observations will be matched to dose level and placebo. This information will be used by the 
physician to make decisions about future medfcation trials. A behavior intervention based on 
the initial functional analysis will be developed for your child. Your child will then receive a 
placebo (fake pill’ ) the same assessments win be completed but a behavior intervention will be 
used to manage the behavior. This assessment will tell you whether or not medication is more 
effective than an appropriate behavior intervention. Your child will be involved in this 
assessment for 3 to 5 weeks.
Benefits: Potential benefits of this study is the development of effective behavioral and medication interventions which may 
help your child increase appropriate behavior, social interaction, and academic engagement Parents and St. 
Mary's staff will be offered feedback on each child's performance. The information can be used to develop an 
appropriate behavior treatment program.
Risks/Discomforts: This study does not provide any additional risks for your child. The only known risks will be the si de­
effects of the Ritalin for which your child has already been prescribed. Your consent for administration 
of this mediation has already been obtained. An explanation of potential side-effects of this medication 
was provided by the training facility when the medication was prescribed.
Rloht to Refuse: Your agreement to allow your child to participate in this prefect is voluntary. You have the right to
withdraw your child from this project at any time, and you may do so by contacting the investigators.
Withdrawal/removal: The medication administered in this study is being supervised by the medical staff at S t Mary's
Training School. The medical staff may discontinue the medication if warranted or remove the child 
from the study if indicated.
Alternatives: This study evaluates three treatments (e.g., medication, no medication, and behavior intervention) and
several types of assessments. Every participant will be evaluated in each treatment. At the end of this 
study, alternatives will be available to each participant
Privacy: The results of this study may be published. The privacy of participants will be protected and the identify of 
participants will not be revealed. All information will be kept confidential.
Release of Information: The facility and school records of the participants in this study may be reviewed by
investigators, but participant identify will be kept secret.
Financial Information. There will be no cost tor participation in this study.
Signatures: The study has been discussed with me and all my questions have been answered. I understand that if I have
questions about subject rights, or other concerns, I can contact the Vice Chancellor or the LSU office of Research and
Economic Development at 388-5833.1 agree with the terms above and acknowledge I have been given a copy of the
consent form.
Signature of the Parent/Guardian Date
Witness Date
Investigators) Date
The parent/guardian has indicated to me that they are unable to read. I certify that I have read this consent form to the 
parent/guardian and explained that by completing the signature line above the parent/guardian has given permission tor their 
child to participate.
Signature of Reader Date
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